Nurses Revision

Pharmacology

Narcotic Drug Abuse and Management

Narcotic Drug Abuse and Management

Narcotic Drug Abuse and Overdose Management

I. Introduction and Definitions

Drug abuse or Substance abuse refers to the use of certain chemicals for the purpose of creating pleasurable effects on the brain, rather than for their intended therapeutic medical purposes. The problem has been increasing at alarming rates globally, especially among young adults.

  • Narcotic Abuse (Opioid Use Disorder): The use of narcotic drugs (opioids) to seek feelings of well-being, euphoria, or numbness, other than for pain killing. It is a complex set of behaviors typically associated with misuse, developing over time with higher drug dosages.
  • Drug Dependence: A state resulting from the interactions of a person and a drug in which the person has a compulsion to continue taking the drug to experience pleasurable psychological effects and sometimes to avoid severe discomfort due to withdrawal. It is divided into:
    • Physical dependence: The body adapts to the drug, and when a person abruptly stops using narcotics, they develop physiological withdrawal symptoms.
    • Psychological dependence: Using the drug for personal satisfaction and craving it, even if the risks and harms are known to the user.
  • Drug Tolerance: A physiological state where more of the drug is needed to produce the same original response. This usually happens with chronic use of drugs causing dependence, pushing the user to take dangerously high doses.

II. Causes and Risk Factors for Narcotic Drug Abuse

Addiction is a biopsychosocial disorder. The reasons for narcotic abuse and dependence include:

  • Curiosity and Experimentation: Wanting to know the taste/effect of the drug and wanting to belong or be accepted in certain peer groups (Peer Pressure).
  • Escapism and Stress: Intermittent use of drugs for social or emotional reasons (e.g., depression, anxiety, PTSD, break-ups, financial burdens, unemployment) to relieve stress or forget problems.
  • Iatrogenic / Irrational Drug Use: Continuous use of a prescribed narcotic for a long time (e.g., chronic pain management) leading to accidental dependence.
  • Genetics and Family History: A family history of substance abuse greatly increases susceptibility to addiction.
  • Availability and Accessibility: Easy access to prescription drugs (e.g., from family medicine cabinets or occupational exposure for healthcare workers) or illicit street drugs.
  • Self-Medication: People with underlying mental health conditions (like ADHD, Depression, or severe anxiety) may use narcotics to self-medicate.
  • Socio-economic factors: Poverty, high work pressure, illegal relationships, and weak drug enforcement laws.

III. Clinical Features and Effects

A. General Effects and Complications of Narcotic Abuse

  • Accidents and severe cognitive impairment.
  • Respiratory illness, pneumonia, and ultimately respiratory arrest.
  • Cardiovascular illness and Hypovolemia/hypotension.
  • Seizures, delirium, and coma.
  • Opioid hyperalgesia: A paradoxical increase in pain sensitivity.
  • Infectious Complications (from IV drug use): Infections at the injection site (abscesses, cellulitis), infective endocarditis, and transmission of blood-borne viruses like HIV and Hepatitis B/C.
  • Severe constipation and bowel obstruction.

B. Signs of Narcotic Intoxication

Intoxication can range from mild to life-threatening. Mental status effects include euphoria, sedation, decreased anxiety, a sense of tranquility, and indifference to pain. Severe intoxication leads to the classic Opioid Overdose Triad.

The Opioid Overdose Triad

  • 1. Coma / Depressed level of consciousness
  • 2. Respiratory Depression (shallow, slow breathing <12 breaths/min)
  • 3. Miosis (Pinpoint pupils)

Other signs include: Slurred speech, hypothermia, cyanosis, needle marks/tracks, and increased sphincter tone leading to urinary retention.

C. Signs of Narcotic Withdrawal

Withdrawal occurs when a physically dependent person stops taking the drug. Symptoms are intensely uncomfortable but rarely fatal.

  • Early Symptoms: Anxiety, agitation, craving, yawning, running nose (rhinorrhea), excessive salivation, and sweating.
  • Late Symptoms: Wide (dilated) pupils (mydriasis), tachypnea, tachycardia, severe muscle aches and bone pain, tremors, lack of appetite, severe abdominal cramps, diarrhea, nausea, and vomiting.

IV. Management of Narcotic Drug Abuse

Step 1: Emergency Reception and Triage

  • Immediate Triage: Patients arriving with suspected narcotic overdose are highly critical. They are often brought in unconscious by bystanders or EMS.
  • A-B-C Approach:
    • Airway: Check if the airway is patent. Clear vomitus or secretions.
    • Breathing: Assess respiratory rate and depth. If the patient is apneic or taking shallow breaths (e.g., 4 breaths/min), initiate bag-valve-mask (BVM) ventilation with 100% oxygen immediately.
    • Circulation: Assess pulses and blood pressure.
  • Move to Resuscitation Area: Any patient with a depressed level of consciousness and respiratory depression must be immediately moved to the Resuscitation/Emergency bay.

Step 2: Acute Assessment and Diagnostics

  • Vital Signs: Continuous SpO2, cardiac monitoring, and frequent BP checks.
  • Neurological Assessment: Check GCS (Glasgow Coma Scale) and examine pupils for miosis (pinpoint).
  • Collateral History: Ask paramedics or bystanders about the scene (empty pill bottles, syringes, history of drug abuse).
  • Screening Tools (for stable/conscious patients): Use the CAGE-AID questionnaire (Adapted to Include Drugs):
    1. Have you ever felt you ought to Cut down on your drug use?
    2. Have people Annoyed you by criticizing your drug use?
    3. Have you felt bad or Guilty about your drug use?
    4. Have you ever had an Eye-opener (used drugs first thing in the morning to steady nerves or get rid of a hangover)?
  • Investigations:
    • Point-of-care capillary blood glucose (to rule out hypoglycemia causing coma).
    • Urine Toxicology screen (confirms presence of opiates).
    • Arterial Blood Gas (ABG) to check for hypoxia and hypercapnia.
    • ECG (to check for QTc prolongation or arrhythmias, especially with Methadone abuse).
    • Screening for HIV, Hepatitis B/C if IV drug use is suspected.

Step 3: Emergency Management & The Antidotes

The primary goal is reversing respiratory depression. Secure IV access immediately.

Specific Narcotic Antidotes:

AntidoteMechanism & CharacteristicsDosage / Administration
Naloxone (Narcan)A pure, short-acting competitive opioid receptor antagonist. It reverses the effects of narcotics (especially respiratory depression) in 1-5 minutes.
Warning: Its half-life (30-90 mins) is much shorter than most narcotics. The patient may slip back into a coma once it wears off, requiring continuous observation or a continuous IV infusion.
0.4 mg to 2 mg IV, IM, SC, or Intranasally. Can be repeated every 2-3 minutes until respiration improves.
NaltrexoneA long-acting narcotic antagonist. It is NOT used for acute overdose. It is used for maintenance therapy to prevent relapse after a patient has been fully detoxified (opioid-free for 7-10 days).Typically 50 mg PO daily for maintenance.
NalmefeneSimilar to naloxone but with a significantly longer half-life, reducing the need for continuous infusions.0.5 mg to 1.5 mg IV.

Note on Antidote Administration: Administering Naloxone to a physically dependent patient will precipitate immediate and severe withdrawal symptoms. Be prepared for agitation, vomiting, and combativeness upon waking.

Step 4: Admission and Location of Care

  • ICU / High Dependency Unit (HDU): Patients requiring intubation, mechanical ventilation, or a continuous Naloxone infusion due to long-acting narcotic overdose (e.g., Methadone) must be admitted here.
  • General Medical Ward / Toxicology Unit: Stable patients who are conscious and breathing adequately, but need observation for 24-48 hours to manage withdrawal and monitor for secondary complications (e.g., aspiration pneumonia).
  • Psychiatric / Rehabilitation Center: Once medically cleared, patients with severe opioid use disorder should be transferred to specialized psychiatric or rehab centers for detox and long-term management.

Step 5: Detoxification and Withdrawal Management

The patient must be motivated and helped to appreciate the disadvantages of drug use. The withdrawal severity is often measured using the COWS (Clinical Opiate Withdrawal Scale). Management involves Medication-Assisted Treatment (MAT):

  • Agonist Substitution Therapy: Substituting the abused drug with a controlled, long-acting opioid to taper them down slowly without euphoria.
    • Methadone: A long-acting synthetic opioid.
    • Buprenorphine: A partial opioid agonist, often combined with naloxone (Suboxone) to prevent IV abuse.
  • Non-Opioid Symptomatic Control:
    • Clonidine: An alpha-2 agonist that heavily relieves autonomic withdrawal symptoms such as salivation, running nose, sweating, muscle aches, and anxiety.
    • Diazepam or Chlordiazepoxide: Benzos for severe anxiety or agitation.
    • Carbamazepine: 200-400mg BD to guard against seizures.
    • Loperamide / Antiemetics: For diarrhea and vomiting.
    • Vitamin B Complex & Multivitamins: For nutritional support.

Step 6: Rehabilitation and Social Reintegration

Addiction is a chronic, relapsing disease. Medical detox is only the first step. Long-term treatment includes:

  • Motivational Counseling: Show the patient they have a problem, identify root causes, and help them build problem-solving skills.
  • Relapse Prevention: Observe behavioral changes, recognize craving triggers, and ensure the client cannot easily access the substance.
  • Group Therapy and Counseling (CBT): Help the client manage difficult feelings, encourage assertiveness, identify relaxation techniques, and use leisure time constructively.
  • Social Reintegration: Encourage support from family and friends. Encourage joining supportive groups like Narcotics Anonymous (NA).
  • Vocational Rehabilitation: Train the client in skills/activities to keep them busy and earn a living.

NURSING CARE AND RESPONSIBILITIES

I. Nursing Responsibilities During Narcotic Administration

  • Legal Compliance (Lock and Key): Narcotics are strictly regulated by federal/national law. Maintain the drugs under double lock and key. The nurse must record the date, time, client's name, type, and amount of the drug used, and sign the entry in a narcotic inventory sheet.
  • Wastage Protocols: If a narcotic drug must be wasted (partially used ampoule), the act must be witnessed by another qualified nurse, and the narcotic sheet must be signed by both the administering nurse and the witness. Computerized narcotic documentation systems should be utilized where available.
  • Antidote Readiness: Always keep narcotic antagonists such as Naloxone readily available on the ward emergency trolley to treat respiratory depression.
  • Pre-Administration Assessment:
    • Assess allergies or adverse effects from narcotics previously experienced by the client.
    • Assess for any respiratory disease (such as asthma or COPD) that might severely increase the risk of respiratory depression.
    • Assess the characteristics of pain and the effectiveness of previous pain medications.
    • Take and record baseline vital parameters (especially Respiratory Rate and SpO2) before administering the drug.
  • Post-Administration Monitoring: Monitor vital signs, Level of Consciousness (L.O.C), pupillary response, bowel function (for severe constipation), urinary function (for retention), and the effectiveness of pain management.
  • Alternative Therapies: Teach and apply non-invasive methods of pain management (e.g., positioning, ice/heat, distraction) in conjunction with narcotic analgesics to avoid narcotic overuse.
  • Avoid Long-term Therapy: Work with physicians to taper narcotics early and avoid long-term therapy unless absolutely medically necessary (e.g., palliative care).

II. Nursing Care Plan for Narcotic Overdose & Withdrawal

No.Nursing DiagnosisInterventions & Rationale
1Ineffective Breathing Pattern related to CNS and respiratory center depression secondary to narcotic overdose.
  • Monitor RR, depth, and SpO2 continuously: Identifies need for immediate intervention.
  • Administer 100% Oxygen and assist ventilation with BVM if RR < 8: Maintains oxygenation to prevent brain death.
  • Administer Naloxone IV as prescribed: Competitively binds opioid receptors to rapidly reverse respiratory depression.
2Risk for Aspiration related to depressed level of consciousness and depressed gag reflex.
  • Position patient in lateral recovery position: Prevents tongue from occluding airway and allows drainage of vomitus.
  • Keep suction equipment at bedside: Ready for immediate clearing of airway if the patient vomits (highly likely after Naloxone administration).
3Acute Pain / Discomfort related to abrupt opioid withdrawal syndrome.
  • Assess withdrawal severity using COWS scale: Guides medication dosing.
  • Administer Clonidine and symptom-relief medications as ordered: Reduces autonomic hyperactivity and physical pain associated with withdrawal.
  • Provide a quiet, dim, non-stimulating environment: Reduces sensory overload which exacerbates withdrawal anxiety.
4Ineffective Coping related to psychological dependence and lack of problem-solving skills.
  • Establish a non-judgmental, therapeutic relationship: Builds trust, encouraging the patient to express feelings about drug use honestly.
  • Assist client to identify triggers for use: Awareness is the first step in relapse prevention.
  • Refer to substance abuse counseling and NA groups: Provides long-term community and psychological support.

III. Client and Family Health Education

  • Proper Medical Use: Reassure patients that the use of narcotics to treat severe, acute pain (under strict doctor supervision) is unlikely to cause addiction. Take drugs exactly as prescribed.
  • Avoid CNS Depressants: Do not drink alcohol or take over-the-counter medications (like antihistamines or sleep aids) unless approved by the health care provider, as this causes fatal respiratory depression.
  • Dietary Adjustments: Increase intake of fluids and fiber in the diet to prevent severe narcotic-induced constipation.
  • Safety Precautions: The drugs often cause dizziness, drowsiness, and impaired thinking. Use extreme caution when driving, operating machinery, or making important decisions.
  • Reporting Symptoms: Report decreasing effectiveness (tolerance) or the appearance of adverse side effects to the physician immediately. Do not self-increase the dose.
  • Overdose Awareness: Teach family members the signs of the overdose triad (coma, slow breathing, pinpoint pupils) and, where available, how to administer take-home emergency Naloxone nasal sprays.
  • Coping Mechanisms: Encourage the client to develop effective coping mechanisms for stress (e.g., exercise, talking to friends) rather than turning to substance use.

Quick Quiz

Narcotic Abuse Quiz

Pharmacology

Privacy: Your details are used only for quiz tracking and certificates.

Narcotic Drug Abuse and Management Read More »

Adverse Drug Reactions

Adverse drug reaction

Adverse Drug Reactions (ADRs)

An adverse drug reaction is a broad term encompassing any unwanted, uncomfortable, or dangerous effect caused by a drug. Understanding ADRs, their classifications, and underlying pharmacological mechanisms is a cornerstone of safe clinical practice and patient care.

I. Objectives

  • Definition of terms associated with Adverse Drug Reactions (ADRs).
  • Classification of ADRs.
  • Discussion on each type of ADR with comprehensive pharmacological examples.

II. Definitions

It is crucial to differentiate between an event and a reaction to establish causality in pharmacovigilance.

  • Adverse Event (AE) / Effect or Experience: Any untoward medical occurrence that may present during treatment with a pharmaceutical product but which does not necessarily have a causal relationship with this treatment.
  • Adverse Drug Event (ADE): An AE which happens in a patient taking a drug.
  • Adverse: Untoward, unintended, possibly causing harm (noxious).
  • Adverse Drug Reaction (ADR): Any noxious change which is suspected to be due to a drug, occurs at doses normally used in man, requires treatment or decrease in dose, or indicates caution in future use of the same drug. Therefore, an adverse drug reaction is an ADE in which a causal association is suspected or established between the drug and the event.

Establishing Causality: ADE vs. ADR Algorithm

  1. Drug Administered: The patient is given a medication.
  2. New Condition/Symptom (ADE): The patient develops an untoward clinical manifestation.
  3. Drug Suspected? (Yes): The clinician suspects the drug is responsible.
  4. Check Literature:
    • Documented: If the reaction is documented for the product or similar class of products → Highly suggestive of ADR.
    • Not documented in literature: The physician must test via dechallenge and rechallenge.
  5. Dechallenge/Rechallenge Process (for undocumented effects):
    • Drug Continued: Worsening of symptoms occurs. The clinician must ask: Are there any other possible causes? (Concomitant therapy, underlying conditions).
    • Drug Discontinued (Dechallenge): If symptoms improve, this is a Positive (+ve) Dechallenge.
    • Drug Restarted (Rechallenge): If symptoms recur upon re-administration, this is a Positive (+ve) Rechallenge, confirming the ADR.

III. Classification of ADRs

Adverse drug reactions can be classified using several parameters to aid in diagnosis, reporting, and management.

1. Depending on Onset of Event:

  • Acute: Occurs in < 60 minutes (e.g., Anaphylaxis).
  • Sub-acute: Occurs in 1 to 24 hours (e.g., Maculopapular rash).
  • Latent: Occurs in > 2 days (e.g., Drug-induced liver injury, teratogenesis).

2. Depending on Severity:

  • Minor ADRs: No therapy, antidote, or prolongation of hospitalization is required.
  • Moderate ADRs: Requires a change in drug therapy, specific treatment, or prolongs hospital stay by at least 1 day.
  • Severe ADRs: Potentially life-threatening, causes permanent damage, or requires intensive medical treatment.
  • Lethal: Directly or indirectly contributes to the death of the patient.

3. Depending on Type of Reaction (Wills and Brown Classification):

The Wills and Brown classification system categorizes ADRs alphabetically from A to H, and U.

  • Type A (Augmented)
  • Type B (Bizarre)
  • Type C (Chemical)
  • Type D (Delayed)
  • Type E (Exit / End of treatment)
  • Type F (Familial)
  • Type G (Genotoxicity)
  • Type H (Hypersensitivity)
  • Type U (Unclassified)

Detailed Discussion on Wills and Brown Classification

Type A (Augmented) Reactions

  • Reactions which can be predicted from the known pharmacology of the drug.
  • Dose-dependent.
  • Can be alleviated by a dose reduction.

Pharmacological Examples & Expansion:

  • Anticoagulants → Bleeding: Drugs like Warfarin (Vitamin K antagonist) or Heparin (activates antithrombin III) have a primary therapeutic action of preventing clot formation. An augmented effect of this known pharmacology naturally leads to spontaneous bleeding or hemorrhage if the dose is too high (e.g., high INR/aPTT).
  • Beta Blockers → Bradycardia: Medications like Metoprolol or Propranolol competitively block beta-1 adrenergic receptors in the heart, preventing sympathetic (epinephrine/norepinephrine) stimulation. While intended to lower blood pressure or control arrhythmias, exaggerated blockade excessively slows the SA node, causing predictable bradycardia.
  • Nitrates → Headache: Nitroglycerin is converted to nitric oxide (NO), stimulating cGMP and causing smooth muscle relaxation. While intended for coronary arteries to treat angina, it also causes profound vasodilation of the meningeal and cerebral blood vessels, predictably leading to a throbbing headache.
  • Prazosin → Postural hypotension: Prazosin is an alpha-1 adrenergic antagonist. It blocks the receptors that normally maintain venous and arterial tone. When a patient stands, the inability of the blood vessels to constrict (due to alpha-1 blockade) causes blood to pool in the lower extremities, leading to a precipitous drop in blood pressure (orthostatic/postural hypotension).

Type B (Bizarre) Reactions

  • Cannot be predicted from the pharmacology of the drug.
  • Not dose-dependent.
  • Host-dependent factors (like genetics or immunological state) are important in predisposition.

Pharmacological Examples & Expansion:

  • Penicillin → Anaphylaxis: The beta-lactam ring of penicillin can act as a hapten, binding to host proteins and triggering an unpredictable, massive IgE-mediated mast cell degranulation (Type I hypersensitivity) in susceptible individuals, leading to anaphylactic shock.
  • Anticonvulsants → Hypersensitivity: Drugs like Phenytoin or Carbamazepine can cause unpredictable immune-mediated reactions such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), or DRESS syndrome. This is often linked to specific HLA genotypes (e.g., HLA-B*1502) affecting how the host metabolizes toxic arene oxide intermediates.

Type C (Chemical) Reactions

  • Biological characteristics can be predicted from the chemical structure of the drug or its metabolite.

Pharmacological Examples & Expansion:

  • Paracetamol (Acetaminophen) → Hepatotoxicity: Paracetamol is normally metabolized by glucuronidation and sulfation. However, a minor pathway via CYP450 enzymes produces a highly toxic, highly reactive intermediate metabolite called NAPQI (N-acetyl-p-benzoquinone imine). In overdose, glutathione stores are depleted, and NAPQI covalently binds to hepatic cellular proteins, causing predictable centrilobular hepatic necrosis.

Type D (Delayed) Reactions

  • Occur after many years of treatment or post-exposure.
  • Can be due to drug or metabolite accumulation.

Pharmacological Examples & Expansion:

  • Chemotherapy → Secondary tumours: Alkylating agents (e.g., Cyclophosphamide) directly cross-link and damage DNA. While they kill primary cancer cells, the cumulative genetic mutations in healthy stem cells can lead to secondary malignancies, such as leukemia, emerging years later.
  • Phenytoin during pregnancy → Teratogenic effects: Exposure in utero can lead to "Fetal Hydantoin Syndrome," characterized by craniofacial anomalies (cleft lip/palate), hypoplastic nails, and developmental delays, manifesting as the child grows.
  • Antipsychotics → Tardive dyskinesia: Long-term use of typical antipsychotics (e.g., Haloperidol) causes chronic blockade of dopamine (D2) receptors in the nigrostriatal pathway. Over years, this leads to an unpredictable up-regulation and hypersensitivity of these receptors, resulting in delayed, involuntary, repetitive body movements.
  • Analgesics → Nephropathy: Chronic, long-term use of NSAIDs inhibits vasodilatory prostaglandins in the kidneys, leading to chronic renal ischemia, papillary necrosis, and chronic interstitial nephritis ("analgesic nephropathy") over years of accumulated use.

Type E (Exit / End of treatment) Reactions

  • Occur on withdrawal, especially when a drug is stopped abruptly.

Pharmacological Examples & Expansion:

  • Phenytoin withdrawal → Seizures: Abrupt cessation of an anticonvulsant removes the pharmacological suppression of neuronal firing. The central nervous system experiences "rebound excitability," which can precipitate severe withdrawal seizures or status epilepticus.
  • Steroid withdrawal → Adrenocortical insufficiency: Exogenous corticosteroids (e.g., Prednisone) exert negative feedback on the Hypothalamic-Pituitary-Adrenal (HPA) axis, shutting down endogenous cortisol production. If stopped abruptly, the atrophied adrenal glands cannot produce enough cortisol to meet physiological demands, leading to a life-threatening acute adrenal crisis.

Other Classifications and Categories of ADRs

1. Side Effects

  • Unwanted but often unavoidable, pharmacodynamic effects that occur at therapeutic doses.
  • Predicted from the pharmacological profile of a drug.
  • Known to occur in a given percentage of drug recipients.

A. Side effect based on therapeutic effect:

  • Atropine (preanaesthetic) → Dryness of mouth: Atropine is a muscarinic acetylcholine receptor antagonist used to reduce airway secretions during surgery. Because it systemically blocks muscarinic receptors, it unavoidably blocks M3 receptors in the salivary glands, causing a dry mouth.
  • Acetazolamide (diuretic) → Acidosis: A carbonic anhydrase inhibitor that forces the renal excretion of bicarbonate to induce diuresis. The loss of the body's primary buffer (bicarbonate) naturally leads to a mild metabolic acidosis.

B. Side effect based on a different action:

  • Promethazine (anti-allergic) → Sedation: It is a first-generation H1 receptor antagonist intended to block peripheral histamine to stop allergies. However, it is highly lipophilic, crosses the blood-brain barrier, and blocks central H1 receptors, leading to significant sedation.
  • Estrogen (Anti-ovulatory / Contraceptive) → Nausea: Estrogen acts centrally on the chemoreceptor trigger zone (CTZ) in the brainstem and can irritate the gastric lining, causing a high incidence of nausea as a side effect.

C. Depending on the context:

  • Codeine (anti-tussive) → Constipation → Used in Traveller's diarrhea: Codeine acts on mu-opioid receptors. In the medullary cough center, it stops coughing. In the GI tract, it decreases peristalsis. While constipation is an unwanted side effect when treating a cough, this exact pharmacodynamic effect is therapeutically exploited to treat diarrhea.

D. Drug Discovery Exploiting Side Effects:

Occasionally, "adverse" effects may be exploited to develop an entirely new indication for a drug.

  • Minoxidil: Originally developed as a potent potassium-channel-opening vasodilator for severely hypertensive patients. An unwanted side effect was hypertrichosis (hair growth). It was subsequently developed as a topical treatment for alopecia.
  • Sildenafil: Initially developed as an antianginal medication to dilate coronary arteries. Its pronounced effect on alleviating erectile dysfunction (by inhibiting PDE-5 and increasing cGMP in the corpus cavernosum) led to a new drug indication.
  • Sulfonamides: Used as antibacterials, they were found to produce hypoglycemia and acidosis as side effects. This led directly to the development of Hypoglycemic Sulfonylureas (for diabetes) and the Carbonic Anhydrase inhibitor Acetazolamide (for glaucoma/diuresis).

2. Secondary Effects

Indirect consequences of a primary action of the drug.

  • Tetracyclines → Suppression of bacterial flora → Superinfections: These broad-spectrum antibiotics kill normal, healthy gastrointestinal and vaginal flora. This secondary disruption allows opportunistic, resistant pathogens (like Candida albicans or Clostridium difficile) to overgrow, causing superinfections.
  • Corticosteroids → Weaken host defence → Activation of latent tuberculosis: Steroids profoundly suppress cell-mediated immunity (T-cells and macrophages). This indirect effect allows dormant granulomas containing Mycobacterium tuberculosis to break open and reactivate.

3. Toxic Effects

Result of excessive pharmacological action of the drug due to over dosage or prolonged use. Overdosage may be:

  • 1. Absolute: Accidental, homicidal, or suicidal ingestion of a massive dose.
  • 2. Relative: Normal dose given to a patient with impaired clearance (e.g., Gentamycin in a patient with Renal failure, leading to toxic accumulation and ototoxicity/nephrotoxicity).

Results of Toxic Effects:

  1. Extension of therapeutic effect:
    • Barbiturates → Coma: (Over-facilitation of GABA-A receptors depressing the entire CNS).
    • Digoxin → Complete A-V block: (Excessive vagal tone and Na/K ATPase inhibition completely stopping atrioventricular conduction).
    • Heparin → Bleeding: (Excessive anticoagulation).
  2. Functional alteration:
    • Atropine → Delirium: (Excessive central anticholinergic toxicity leads to hallucinations and delirium, independent of its intended peripheral effects).
  3. Drug induced tissue damage:
    • Paracetamol → Hepatic necrosis: (Via toxic NAPQI metabolite).

4. Intolerance vs. Idiosyncrasy

Intolerance:

  • Appearance of characteristic toxic effects of a drug in an individual at therapeutic doses.
  • It is the converse of tolerance and indicates a very low threshold of the individual to the drug's normal actions.
  • Triflupromazine (single dose) → Muscular dystonias in some individuals (acute extrapyramidal symptoms from standard D2 blockade).
  • Carbamazepine (few doses) → Ataxia in some individuals (excessive sodium channel blockade in the cerebellum at low doses).
  • Chloroquine (single tablet) → Vomiting and abdominal pain in some individuals.

Idiosyncrasy:

  • Genetically determined abnormal reactivity to a chemical.
  • Certain bizarre drug effects due to peculiarities of an individual for which no definite genotype has been described are also included.
  • The drug interacts with some unique feature of the individual, not found in the majority of subjects, and produces an uncharacteristic reaction.
  • Barbiturates → Excitement and mental confusion in some individuals (paradoxical reaction).
  • Quinine → Cramps, diarrhea, asthma, vascular collapse in some individuals (severe idiosyncratic reaction known as Cinchonism).
  • Chloramphenicol → Aplastic anemia in rare individuals (idiosyncratic, non-dose-dependent bone marrow failure due to genetic susceptibility affecting mitochondrial protein synthesis).

5. Drug Allergy (Drug Hypersensitivity)

Immunologically mediated reaction producing stereotype symptoms, unrelated to the pharmacodynamic profile of the drug. Generally occurs even with much smaller doses.

  • Type I: Immediate, anaphylactic (IgE-mediated)
    • Penicillins → Anaphylaxis
  • Type II: Cytotoxic antibody (IgG, IgM-mediated)
    • Methyldopa → Hemolytic anemia (Drug binds to RBC membrane; IgG antibodies attack and destroy the red blood cells).
  • Type III: Serum sickness (IgG, IgM Antigen-antibody complex)
    • Procainamide-induced lupus (Complexes of drug and antibodies deposit in tissues and joints, causing systemic lupus erythematosus-like symptoms).
  • Note: Types I, II, and III constitute Humoral immunity.
  • Type IV: Delayed hypersensitivity (T cell-mediated)
    • Contact dermatitis (Topical drug exposure activates localized T-cells leading to delayed skin inflammation).
  • Note: Type IV constitutes Cell-mediated immunity.

6. Photosensitivity

Cutaneous reaction resulting from drug-induced sensitization of the skin to UV radiation. The reactions are of two types:

  • Phototoxic: Drug or its metabolite accumulates in the skin, absorbs light, and undergoes a photochemical reaction resulting in local tissue damage (sunburn-like, i.e., erythema, edema, blistering, hyperpigmentation).
    • Tetracyclines (esp. Demeclocycline), Tar products, Nalidixic acid, Fluoroquinolones, Sulfones, etc.
  • Photo allergic: Drug or its metabolite induces a cell-mediated immune response which on exposure to light (longer wave length) produces a papular or eczematous contact dermatitis-like picture.
    • Sulfonamides, Sulfonylureas, Griseofulvin, Chloroquine, Chlorpromazine.

7. Drug Dependence & Withdrawal

Drugs capable of altering mood and feelings are liable to repetitive use to derive euphoria, withdrawal from reality, social adjustment, etc.

Types of Dependence:

  • Psychological dependence: Individual believes that optimal state of well being is achieved only through the actions of the drug. (e.g., Opioids, Cocaine).
  • Physical dependence: Altered physiological state produced by repeated administration of a drug which necessitates the continued presence of the drug to maintain physiological equilibrium. Discontinuation of the drug results in a characteristic withdrawal (abstinence) syndrome. (e.g., Opioids, Barbiturates, Alcohol, Benzodiazepines).

Terminology:

  • Drug abuse: Use of a drug by self medication in a manner and amount, that deviates from the approved medical and social patterns in a given culture at a given time. Refers to any use of an illicit drug.
  • Drug addiction: Compulsive drug use characterized by overwhelming involvement with the use of a drug.
  • Drug habituation: Less intensive involvement with the drug, withdrawal produces only mild discomfort.
  • Habituation and addiction imply different degrees of psychological dependence.

Drug Withdrawal Reactions:

Sudden interruption of therapy with certain drugs result in adverse consequences, mostly in the form of worsening of the clinical condition for which the drug was being used.

  • Corticosteroid → Adrenal insufficiency
  • β-blockers → Worsening of angina, precipitation of Myocardial Infarction (MI) (Due to up-regulation of beta receptors during chronic blockade; abrupt withdrawal leaves the heart hypersensitive to endogenous catecholamines).
  • Clonidine → Severe HTN, restlessness, sympathetic over activity (Alpha-2 agonist withdrawal removes central sympathetic inhibition, causing a massive rebound catecholamine release).

8. Teratogenicity, Mutagenicity, Carcinogenicity, and Iatrogenic Disease

Teratogenicity:

Capacity of a drug to cause foetal abnormalities when administered to the pregnant mother. Drugs can affect the foetus at 3 stages:

  1. Fertilization and implantation (Conception to 17 days): Failure of pregnancy which often goes unnoticed (all-or-nothing effect).
  2. Organogenesis (18 days to 55 days): Most vulnerable period, major structural deformities are produced.
  3. Growth and development (> 56 days): Developmental and functional abnormalities can occur.
  • Thalidomide → Phocomelia, multiple defects (Thalidomide acts as an angiogenesis inhibitor, preventing proper blood vessel formation required for limb bud development in the fetus).
  • Anticancer drugs → Cleft palate, hydrocephalus, multiple defects (Directly disrupts DNA synthesis and rapid cell division in the developing embryo).
  • ACE inhibitors → Hypoplasia of organs (lungs, kidney) (Blocks the fetal renin-angiotensin system, causing severe fetal hypotension, renal failure, and oligohydramnios, which restricts lung development).

Mutagenicity and Carcinogenicity:

Capacity of a drug to cause genetic defects and cancer respectively. Chemical carcinogenesis generally takes several (10-40) years to develop.

  • Anticancer drugs (Direct DNA damage/alkylation).
  • Radio-isotypes (Radiation-induced chromosomal breaks).
  • Estrogens (Proliferative stimuli on hormone-sensitive tissues like endometrium/breast).
  • Tobacco (Contains numerous chemical carcinogens like benzopyrenes).

Drug induced disease (Iatrogenic):

Also called Iatrogenic (Physician induced) diseases. Functional disturbances caused by drugs which persist even after the offending drug has been withdrawn and largely eliminated.

  • Salicylates (Aspirin), Corticosteroids → Peptic ulcer (Aspirin inhibits COX-1, depleting protective gastric prostaglandins. Corticosteroids decrease gastric mucosal cell renewal).
  • Phenothiazines, other antipsychotics → Parkinsonism (Chronic dopamine D2 receptor blockade in the basal ganglia mimics the pathology of Parkinson's disease).
  • Isoniazid → Hepatitis (Metabolized into toxic hydrazine metabolites that damage hepatocytes).
  • Hydralazine → DLE (Discoid / Drug-induced Lupus Erythematosus) (Alters host proteins in slow acetylators, triggering an autoimmune antibody response against the host's own DNA).

IV. Summary

  • Adverse Drug Reactions (ADRs) are adverse events with a causal link to a drug.
  • Types of Classification of ADRs:
    • Onset of event: Acute (<60 minutes), Sub-acute (1-24 hrs) and Latent (>2 days).
    • Type of reaction: Type A (Augmented), B (Bizarre), C (Chemical), D (Delayed), E (Exit), F (Familial), G (Genotoxicity), H (Hypersensitivity), U (Unclassified).
    • Severity: Minor, Moderate, Severe, Lethal ADRs.
    • Others: Side effects, Secondary effects, Toxic effects, Intolerance, Idiosyncrasy, Drug allergy, Photosensitivity, Drug Dependence, Drug Withdrawal Reactions, Teratogenicity, Mutagenicity, Carcinogenicity, Drug induced disease (Iatrogenic).

References

  • Bhushanam T., V. (n.d.). Adverse Drug Reactions [PDF Presentation slides].
  • Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2017). Goodman & Gilman's The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education. (Used for pharmacological expansions).
  • Katzung, B. G. (2017). Basic & Clinical Pharmacology (14th ed.). McGraw-Hill Education. (Used for pharmacological expansions).
  • World Health Organization (WHO). (2002). Safety of Medicines: A guide to detecting and reporting adverse drug reactions. WHO Press.

Quick Quiz

Adverse Reactions Quiz

Pharmacology

Privacy: Your details are used only for quiz tracking and certificates.

Adverse drug reaction Read More »

Cholinergic Receptors, Signaling, and Effects

Cholinergic Receptors, Signaling, and Effects

Cholinergic Receptors, Signaling, and Effects

Module Learning Objectives

By the conclusion of this exhaustive master guide, you will be deeply conversant with:

  • The major systems and specific organs innervated by Autonomic Cholinergic systems.
  • The complete lifecycle of Acetylcholine (ACh): synthesis, storage, release, and degradation, along with the specific drugs that block each step.
  • The distinct tissue expression profiles and molecular signaling mechanisms of Nicotinic (N) and Muscarinic (M) receptors.
  • The profound organ system effects resulting from cholinergic stimulation (toxicity) versus cholinergic antagonism, memorized via classic clinical mnemonics.

I. Introduction: The Cholinergic Neuron and Autonomic Innervation

In the vast communication network of the nervous system, Acetylcholine (ACh) is arguably the most widely utilized neurotransmitter. Neurons that synthesize, store, and release ACh are explicitly termed Cholinergic Neurons.

To master pharmacology, you must first memorize the exact anatomical locations where ACh acts as the primary messenger. ACh is NOT just a parasympathetic chemical; its reach is much broader.

Where is Acetylcholine Used?

  • All Autonomic Ganglia: Both Sympathetic and Parasympathetic preganglionic fibers release ACh to stimulate nicotinic receptors on the postganglionic neuron.
  • All Postganglionic Parasympathetic Fibers: These release ACh directly onto target organs (heart, gut, glands) to stimulate muscarinic receptors.
  • The Adrenal Medulla: Sympathetic preganglionic fibers release ACh directly into the adrenal medulla to trigger the massive systemic release of Adrenaline/Noradrenaline into the blood.
  • The Somatic Nervous System (Voluntary Muscle): Motor neurons release ACh directly onto skeletal muscle to trigger voluntary movement via Nicotinic (N M) receptors.
  • The Sympathetic "Exception" (Sweat Glands): While almost all sympathetic postganglionic fibers release Noradrenaline, the sympathetic fibers innervating eccrine sweat glands uniquely release ACh to stimulate muscarinic receptors.
  • The Central Nervous System (CNS): Cholinergic neurons play vital roles in the brain regarding memory, learning, and arousal. (Pathology Note: The profound loss of cholinergic neurons in the brain is a hallmark of Alzheimer's Disease).

II. The Lifecycle of Acetylcholine (Neurotransmission)

The synapse is the site most amenable to pharmacological manipulation. We can design drugs to target every single stage of ACh's life. The lifecycle consists of five distinct sequential steps.

Step 1: Synthesis

Making the Neurotransmitter

  • The Ingredients: ACh is synthesized in the nerve terminal cytosol from two precursors: Choline and Acetyl Coenzyme A (Acetyl-CoA).
  • The Process: Choline is transported from the extracellular fluid into the neuron by a sodium-dependent, energy-requiring active transport carrier. Because Choline has a quaternary nitrogen (carrying a permanent positive charge), it cannot diffuse passively through the membrane. Acetyl-CoA is produced by the mitochondria.
  • The Enzyme: Choline Acetyltransferase (ChAT) catalyzes the reaction, merging them to form ACh.
  • The Rate-Limiting Step: The active uptake of choline into the cell is the bottleneck.
  • Drug Intervention: Hemicholinium is a research drug that blocks the choline transporter, starving the cell of raw materials and preventing ACh synthesis.
Step 2: Storage

Packaging for the Future

  • The Process: Once synthesized, free-floating ACh is rapidly packaged into presynaptic vesicles to protect it from degradation. This is an active transport process driven by the efflux of protons (H+).
  • Cotransmission: A mature vesicle is not just full of ACh. It contains ACh + ATP + Proteoglycans. ATP acts as a cotransmitter at prejunctional purinergic receptors to provide negative feedback.
  • Drug Intervention: Vesamicol acts as a blockade here. It inhibits the vesicular ACh transporter (VAT), preventing ACh from being loaded into vesicles. The empty vesicles are useless upon release.
Step 3: Release

The Calcium Trigger

  • The Process: An action potential (electrical wave driven by Na+ channels) arrives at the nerve terminal. This electricity forces Voltage-Sensitive Calcium (Ca 2+) Channels to snap open.
  • The Trigger: Ca 2+ rushes into the cell. Elevated intracellular calcium causes the ACh vesicles to fuse tightly with the presynaptic membrane (via SNARE proteins) and dump their contents into the synaptic cleft via exocytosis.
  • Drug Intervention (Blockade): Botulinum Toxin (Botox) destroys the SNARE fusion proteins. Without fusion, ACh is trapped inside. This causes severe flaccid paralysis. (Clinically used to treat muscle spasms, excessive sweating, and wrinkles).
  • Drug Intervention (Massive Release): Black Widow Spider Venom (α-Latrotoxin) forces all the stored vesicles to dump their ACh into the cleft at once, causing violent muscle cramps and spastic paralysis, followed eventually by depletion.
  • Advertisements

Step 4: Receptor Binding

Action and Feedback

  • Post-synaptic Binding: ACh diffuses across the microscopic synaptic cleft and binds to post-synaptic receptors (Muscarinic or Nicotinic), triggering the physiological response in the target organ.
  • Pre-synaptic Modulation: ACh also binds to pre-synaptic autoreceptors, which act as a thermostat to provide negative feedback and regulate further release.
Step 5: Degradation & Recycling

Termination

  • Enzymatic Cleavage: Unlike other neurotransmitters that undergo reuptake whole, ACh action is terminated by rapid hydrolysis in the synaptic cleft.
  • The Enzyme: Acetylcholinesterase (AChE) is one of the fastest enzymes in the body, cleaving ACh into Acetate and Choline in milliseconds.
  • Choline Recycling: The leftover Choline is recaptured by the high-affinity sodium-coupled transporter (ChT) to be recycled into the next batch of neurotransmitter.

Chemistry Deeper: The Mechanism of Acetylcholinesterase (AChE)

Understanding how AChE destroys Acetylcholine is crucial because blocking this enzyme is a major pharmacological strategy. The degradation involves precise chemical steps within the enzyme's active site:

  1. Binding: ACh binds to the active site of AChE.
  2. Transient Intermediate: A temporary chemical bond forms involving the -OH group of Serine 203 (as well as Glutamate and Histidine residues in the catalytic triad).
  3. Cleavage: Choline is broken off and released, leaving the enzyme temporarily "acetylated" (holding the acetate piece).
  4. Deacylation: Water enters and rapidly strips the acetate off the enzyme, regenerating the naked AChE so it can instantly destroy the next ACh molecule.

III. Indirect Cholinergic Agonism (AChE Inhibitors)

If we want to stimulate the parasympathetic nervous system, we can either give a drug that acts exactly like ACh (a Direct Agonist like Carbachol or Pilocarpine), or we can use a much more devious strategy: Indirect Agonism.

Mechanism: Indirect agonists do NOT bind to the receptor. Instead, they attack and disable Acetylcholinesterase (AChE). By killing the "garbage men" of the synapse, natural ACh builds up to massive, localized concentrations, continuously hammering the receptors. The net effect is powerfully agonistic.

  • Reversible Inhibitors: These drugs temporarily bind to AChE (for minutes to hours).
    Examples: Physostigmine (crosses into the brain, used for anticholinergic toxicity), Neostigmine (does not cross into the brain, used heavily to treat Myasthenia Gravis to increase ACh at the muscles).
  • Irreversible Inhibitors: These permanently, covalently bind to the Serine residue of AChE. The enzyme is dead forever. The body must spend days synthesizing brand new enzymes.
    Examples: Organophosphates (found in lethal nerve gases like Sarin, and agricultural insecticides like Parathion). This causes a terrifying, often fatal toxic cascade (The SLUDGE/DUMBELS crisis).

IV. The Cholinergic Receptors: Nicotinic (N)

ACh exerts its magic by interacting with two vastly different families of receptors. We begin with the Nicotinic receptors, named because they are activated by the plant alkaloid Nicotine (from Nicotiana tabacum).

Receptor Physiology: The Ligand-Gated Ion Channel

Nicotinic receptors are Ionotropic. They do not use slow G-proteins. The receptor itself physically surrounds a central pore. When two ACh molecules bind to the outer α-subunits, the pore snaps open instantly. Sodium (Na+) rushes in, causing rapid, localized depolarization. If enough Na+ enters, an action potential fires or a muscle violently contracts.

Dose-Dependent Phenomenon: In small doses, Nicotine stimulates autonomic ganglia. However, if massive, continuous doses are applied, the receptor becomes exhausted and locked in a desensitized state. Thus, intense stimulation is quickly followed by a total blockade of transmission.

Advertisements

Nicotinic Subtypes and Locations:

  • N N (Nicotinic-Neuronal): Located in ALL autonomic ganglia and the Adrenal Medulla. Controls the firing of post-ganglionic nerves and adrenaline secretion.
  • N M (Nicotinic-Muscle): Located on the somatic motor end-plate of voluntary skeletal muscle. Controls voluntary muscle contraction.

Nicotinic Receptor Antagonists (Blockers)

In surgery, we need to paralyze muscles so the surgeon can cut without the patient twitching. We use Neuromuscular Blocking Agents (NMBAs) which target the N M receptor. They come in two distinct flavors:

  1. Competitive (Non-Depolarizing) Blockers: These are bulky drugs that physically sit over the ACh binding site like a heavy cap. They do nothing but block the door.
    Example: Curare derivatives, Pancuronium, Rocuronium.
  2. Depolarizing (Destructing) Blockers: A fascinating, dangerous mechanism. The drug acts as a super-agonist. It binds and opens the channel, causing a massive initial muscle twitch (fasciculation). But unlike ACh, the drug refuses to let go. It locks the channel open. The muscle membrane becomes utterly exhausted (depolarized block / Phase I block) and physically cannot fire again until the drug washes away.
    Example: Succinylcholine. It provides ultra-fast, profound paralysis for emergency intubation.

V. The Cholinergic Receptors: Muscarinic (M)

The second family is named after Muscarine, a toxin extracted from the poisonous fly agaric mushroom (Amanita muscaria). These are responsible for the classic "Parasympathetic" (Rest & Digest) organ responses.

Unlike Nicotinic receptors, Muscarinic receptors are Metabotropic (G-Protein Coupled Receptors). They do not have built-in ion channels. Instead, they snake through the membrane 7 times and rely on internal G-proteins to alter cellular chemistry. There are 5 subtypes (M 1 to M 5), all found in the CNS, but heavily distributed in specific peripheral organs.

SubtypeG-Protein PathwayPrimary LocationsClinical Effect of Stimulation
M 1 (Neural/Enteric)G q (Excitatory)CNS, Enteric Nervous System, Gastric Parietal CellsCNS excitation, massive increase in Gastric Acid secretion.
M 2 (Cardiac)G i (Inhibitory)Heart (SA node, AV node, Atria), Presynaptic terminalsCardiac Inhibition: Severe decrease in heart rate (Bradycardia) and conduction velocity.
M 3 (Glandular/Smooth Muscle)G q (Excitatory)Exocrine glands (saliva, sweat, tears), Visceral Smooth Muscle (gut, bladder, bronchi), Blood vessels (endothelium)The Workhorse: Massive glandular secretion, powerful contraction of visceral smooth muscle (causes bronchoconstriction and urination). *Promotes Vasodilation via Nitric Oxide (NO) release from endothelium.
M 4 (Neural)G i (Inhibitory)Central Nervous SystemNeuronal inhibition.
M 5 (Neural)G q (Excitatory)Central Nervous SystemCNS excitation.

Deeper: Mechanisms of Muscarinic Signal Transduction

You must understand how the G-proteins actually force these cellular changes:

  • The Excitatory Pathway (M 1, M 3, M 5 via G q):
    Activation forces the G q protein to activate an enzyme called Phospholipase C (PLC). PLC hacks a membrane lipid into two highly potent second messengers: IP 3 (Inositol 1,4,5-trisphosphate) and DAG (Diacylglycerol). IP 3 rips open calcium vaults inside the cell, causing a massive increase in intracellular Ca 2+. This calcium instantly triggers smooth muscle contraction (e.g., gut cramping) and glandular secretion (e.g., sweating). DAG activates Protein Kinase C to further amplify the signal.
  • The Inhibitory Pathway (M 2, M 4 via G i):
    Activation forces the G i protein to actively inhibit Adenylyl Cyclase, violently dropping cellular cAMP levels. Simultaneously, it pushes open Potassium (K+) channels. As K+ leaks out of the cell, the cell loses positive charge, becoming severely hyperpolarized (Slow IPSP). This makes the cell incredibly difficult to fire, which is exactly why M 2 stimulation puts the brakes on the heart rate.
  • Advertisements


VI. Clinical Manifestations of Excessive Cholinergic Effects (Toxicity)

If a patient overdoses on a direct cholinergic agonist (like Pilocarpine) or an indirect agonist (like an Organophosphate pesticide/Sarin gas), they experience a terrifying, full-body physiological crisis. Every Muscarinic receptor fires at maximum capacity.

This is easily memorized via two classic, highly testable mnemonics: DUMBELS and the expanded BAG the PUDDLES.

The Core Symptoms (DUMBELS)
  • D - Defecation: Severe diarrhea (M 3 gut hypermotility).
  • U - Urination: Incontinence (M 3 forces the detrusor muscle to squeeze).
  • M - Miosis: Pinpoint pupils (M 3 forces the sphincter pupillae to cramp).
  • B - Bradycardia & Bronchospasm: The heart nearly stops (M 2) and the lungs clamp shut (M 3).
  • E - Emesis: Vomiting.
  • L - Lacrimation: Continuous crying/tears.
  • S - Salivation & Sweating: Frothing at the mouth and dripping with sweat.
Expanded View (BAG the PUDDLES)
  • B - Bronchoconstriction
  • A - Apnea (Failure of the respiratory center)
  • G - Graying/Dimming of vision
  • P - Pupillary constriction (Miosis)
  • U - Urination
  • D - Diaphoresis (Massive sweating)
  • D - Defecation
  • L - Lacrimation
  • E - Emesis
  • S - Seizures (Due to massive CNS overstimulation).

*The ultimate cause of death in cholinergic crisis is respiratory failure (drowning in bronchial secretions while the airways are cramped shut).


VII. Effects of Muscarinic Antagonists (Anticholinergics)

To reverse a cholinergic crisis, or to treat specific diseases, we administer Muscarinic Antagonists. The prototype drug is Atropine (derived from the Deadly Nightshade plant, Atropa belladonna). By blocking M receptors, you strip away the parasympathetic "brakes," leaving the sympathetic nervous system unopposed.

The effects of an Anticholinergic overdose are legendary and captured in the most famous medical rhyme:

"Dry as a bone, blind as a bat, red as a beet, mad as a hatter, and hot as a hare."

  • Dry as a bone: Complete blockade of M 3 receptors causes a cessation of sweating, salivation, and lacrimation. The mouth feels like sandpaper.
  • Blind as a bat: Blockade in the eye causes massive pupil dilation (Mydriasis) because the constrictor muscle is paralyzed. It also paralyzes the ciliary muscle (Cycloplegia), leading to a complete loss of visual focus and intense photophobia (sensitivity to light).
  • Red as a beet: Because the body can no longer sweat to cool down, it attempts to radiate heat by undergoing reflex peripheral (cutaneous) vasodilation, making the skin flushed and bright red.
  • Mad as a hatter: Severe CNS penetration of the drug leads to central muscarinic blockade, causing intense agitation, hallucinations, delirium, and eventually coma.
  • Hot as a hare: The lack of sweating causes body temperature to spike dangerously (Hyperthermia), which is especially lethal in young children.

Other Critical Anticholinergic Effects:

  • Tachycardia: Blocking the M 2 "brakes" on the heart allows the resting heart rate to surge. (Atropine is used in emergencies to treat severe bradycardia).
  • Bronchodilation: Relaxing the airways. (Drugs like Ipratropium are used in asthma and COPD inhalers to keep airways open).
  • GI and Bladder Atony: The gut stops moving (causing severe constipation) and the bladder goes flaccid (causing urinary retention). (Drugs like Oxybutynin are used to treat an overactive, leaky bladder).

  • Katzung, B. G., & Trevor, A. J. (2020). Basic & Clinical Pharmacology (15th ed.). McGraw-Hill Education. (Deep-dive into receptor pharmacology and specific drug actions).
  • Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2017). Goodman & Gilman's: The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill. (Gold standard text for the molecular biochemistry of Acetylcholinesterase and G-protein signaling).
  • Harvey, R. A., Clark, M. A., Finkel, R., Rey, J. A., & Whalen, K. (2011). Lippincott's Illustrated Reviews: Pharmacology (5th ed.). Lippincott Williams & Wilkins. (Excellent visual summaries of DUMBELS and Anticholinergic toxidromes).

Quick Quiz

Cholinergic Receptors Quiz

Pharmacology

Privacy: Your details are used only for quiz tracking and certificates.

Advertisements

Cholinergic Receptors, Signaling, and Effects Read More »

NSAIDs & Prostanoids

NSAIDs & Prostanoids

NSAIDs & Prostanoids

NSAIDs & Prostanoids Pharmacology

Module Overview

This master guide covers the pharmacology of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Prostanoids. We will explore the Arachidonic Acid pathway, the profound differences between COX-1 and COX-2, specific drug classifications, and the synthetic prostanoids used to manipulate everything from childbirth to glaucoma. Enhanced with clinical scenarios and deep-dive explanations to guarantee exam success.


1. The Foundation: Prostanoids and the MOA of NSAIDs

Before understanding the drugs, you must understand the assembly line that makes the molecules these drugs block. This is the Arachidonic Acid Pathway. Think of this pathway as a factory that takes raw materials from the cell wall and turns them into highly active chemical messengers.

MEMBRANE PHOSPHOLIPIDS

↓
Enzyme: Phospholipase A2 (BLOCKED by Corticosteroids)
↓

ARACHIDONIC ACID

↙

Lipoxygenase

↓

Leukotrienes
(Cause Bronchospasm/Asthma)

↘

Cyclooxygenase (COX)
(BLOCKED by NSAIDs)

↓

PGG2 → PGH2
(Endoperoxides)

↓

PROSTANOIDS:
Prostaglandins (PGE2, PGF2α, PGD2)
Thromboxane (TXA2)
Prostacyclin (PGI2)

Clinical Pearl

Steroids vs. NSAIDs & The "Shunt" Phenomenon

Notice that Corticosteroids block the pathway at the very top (Phospholipase). Therefore, steroids stop BOTH Leukotrienes (which cause asthma) and Prostanoids. NSAIDs only block the COX enzyme lower down.

This means NSAIDs stop pain and fever (Prostanoids) but do nothing to stop Leukotrienes. In fact, in some asthma patients, giving an NSAID creates a "Leukotriene Shunt". Because the COX pathway is blocked, all the built-up Arachidonic acid is violently pushed down the Lipoxygenase pathway, causing a massive overproduction of Leukotrienes. This triggers a severe, life-threatening asthma attack (a condition clinically known as Aspirin-Exacerbated Respiratory Disease or AERD).

The Cyclooxygenase (COX) Isozymes: The "Housekeeper" vs. The "Fire Alarm"

The COX enzyme comes in different versions (isoforms). Knowing the difference is the absolute key to understanding NSAID side effects and why pharmaceutical companies spent billions inventing specific COX-2 inhibitors.

COX-1 (The Housekeeper)COX-2 (The Fire Alarm)COX-3 (The Mystery)
  • Constitutive: Always active, working in the background 24/7.
  • Responsible for physiologic production of prostanoids to regulate normal cellular processes.
  • Gastric Cytoprotection: Makes protective stomach mucus and neutralizes stomach acid.
  • Vascular Homeostasis & Platelet Aggregation: Balances blood flow and clotting.
  • Kidney Function: Regulates and maintains renal blood flow.
  • Inducible: Normally absent, but ramps up massively during emergencies (trauma, infection).
  • Responsible for elevated production of prostanoids in disease states.
  • Expression at sites greatly increases to cause Pain, Inflammation, and Fever.
  • (Also expressed normally in brain, kidney, and bone).
  • Predominantly has effects in the Central Nervous System (CNS).
  • Often theorized to be the exact target of Acetaminophen (Paracetamol) which beautifully explains why it reduces fever/pain centrally in the brain but has absolutely no anti-inflammatory effect in the body's tissues.

2. Classification of NSAIDs

NSAIDs are classified either by their chemical structure/efficacy or by how selectively they block the COX enzymes.

Classification by COX Selectivity (The Slide 4 Breakdown)

Note on exam preparation: Some drugs straddle the line of selectivity based on dose. For example, Aspirin is selective for COX-1 at low doses, but non-selective at high doses.

  • Selective COX-1 Inhibitors (Usually low doses): Low dose Aspirin, Ketoprofen, Flurbiprofen, Indomethacin, and Ketorolac (sometimes spelled 'Ketoloid' on older slides).
  • Non-Selective COX Inhibitors (Traditional NSAIDs): Piroxicam, Tenoxicam, Ibuprofen, Naproxen, Diclofenac. These hit both COX-1 and COX-2 equally, killing pain but ruining the stomach.
  • Selective COX-2 Inhibitors (The "-coxibs" & friends): Celecoxib, Etoricoxib, Meloxicam (preferential), Nimesulide. Designed to kill pain without giving you a stomach ulcer.

Classification by Efficacy and Chemical Class (The Slide 5 Breakdown)

Why do we care about chemical classes? Because if a patient is highly allergic or fails to respond to an NSAID from the "Propionic Acid" class, a wise doctor will switch them to a completely different chemical class, like an "Oxicam".

1. Analgesic & Marked Anti-inflammatory

Non-Selective COX Inhibitors (Traditional)

  • Salicylic Acid Derivatives: Aspirin
  • Propionic Acid Derivatives: Naproxen, Ibuprofen, Ketoprofen
  • Pyrazolon Derivatives: Phenylbutazone
  • Acetic Acid Derivatives: Diclofenac, Aceclofenac, Nebumetone, Sulindac
  • Pyrrolo-pyrrole Derivatives: Ketorolac
  • Indole Derivatives: Indomethacin
  • Oxicams: Piroxicam, Tenoxicam
2. Analgesic & Moderate Anti-inflammatory
  • Fenamates: Meclofenamic acid, Tolfenamic acid, Flufenamic acid
  • Anthranilic acid: Mefenamic acid

3. Preferential & Selective COX-2
  • Preferential COX-2 Inhibitors: Meloxicam, Nimesulide.
  • Selective COX-2 Inhibitors: Celecoxib, Etoricoxib.

4. Analgesics with POOR/NO Anti-inflammatory
  • Para-aminophenol Derivatives: Acetaminophen/Paracetamol.

3. Mechanism of Action (MOA) and General Adverse Effects

Primary MOA: NSAIDs inhibit the cyclooxygenase (COX) enzyme, resulting in the reduced biosynthesis of Prostanoids (Prostaglandins, Prostacyclin, and Thromboxane A2).

Why do Traditional NSAIDs cause side effects?

Aspirin and older, non-selective NSAIDs block BOTH COX-1 and COX-2. By blocking COX-2, they brilliantly stop inflammation, pain, and fever. BUT, by blocking COX-1, the release of PGs required for homeostatic (housekeeping) function is totally disrupted.

The Mechanisms of Toxicity

  • The Stomach: PGE2 and PGI2 normally stimulate the production of thick, protective gastric mucus and bicarbonate. They also maintain rich blood flow to the stomach wall. NSAIDs stop this synthesis.
    Result: The stomach acid literally burns through the unprotected stomach wall, causing Gastric and Duodenal Ulcers, and severe GI Bleeding.
  • The Kidneys: PGE2 and PGI2 are responsible for actively dilating the afferent renal arteriole (the blood vessel bringing blood INTO the kidney filter), which maintains the Glomerular Filtration Rate (GFR). If you block this (especially in elderly patients with already impaired kidneys or low blood volume), blood flow to the kidney drops sharply.
    Result: Serious kidney damage, acute renal failure, and severe fluid retention.

General Adverse Reactions of NSAIDs (System by System)

  • Gastrointestinal Tract (Most Common): Nausea, vomiting, diarrhea, constipation, epigastric pain, indigestion, abdominal distress, intestinal ulceration, stomatitis, jaundice, bloating, anorexia, and dry mouth.
  • Central Nervous System (CNS): Dizziness, headache, drowsiness, insomnia.
  • Cardiovascular: Decrease or increase in blood pressure (often increasing it due to fluid retention), and cardiac arrhythmias.
  • Renal: Hematuria (blood in urine) and acute renal failure (in those with pre-existing impaired function).
  • Special Senses: Visual disturbances, blurred or diminished vision.
  • Hematologic: Anemia (often secondary to chronic microscopic GI bleeding over months of daily NSAID use).

4. Deep Dive: Aspirin, Acetaminophen, and Selective COX-2s

A. ASPIRIN (Acetylsalicylic Acid)

Aspirin is completely unique among all NSAIDs. It irreversibly acetylates both isoforms of the COX enzyme. This means it covalently binds to the enzyme and kills it permanently. The cell must synthesize brand new enzymes from scratch to recover function. For a normal cell, this takes hours to days. But for platelets (which have no nucleus and cannot make new proteins!), the enzyme is dead for the entire 7-10 day lifespan of the platelet.

  1. As an Anti-inflammatory: Inhibits PG biosynthesis to modulate inflammation. Used in Rheumatoid Arthritis (RA), but note: it only helps the symptoms, it neither arrests nor cures the progress of the disease.
  2. As an Analgesic (Painkiller): Reduces production of PGE2. PGE2 normally sensitizes nerve endings to pain. By blocking it, Aspirin represses pain sensation. Used for toothache, dysmenorrhea (menstrual pain), and post-operative pain (often used alongside opioids to reduce the opioid dose). It also inhibits pain stimuli at subcortical sites (Thalamus & Hypothalamus).
  3. As an Antipyretic (Fever Reducer): Aspirin lowers raised body temperature by acting on the hypothalamus (resetting the brain's thermostat). It has no effect on normal body temperature.
  4. As an Antiplatelet (Blood Thinner): In low doses (e.g., 75mg - Ecorin-75), it permanently inhibits platelet aggregation because it stops the production of TXA2 (which normally promotes clotting). Used globally to prevent heart attacks and strokes.

Aspirin: Adverse Effects & Contraindications

Adverse Effects:

  • GI disturbances (Can be prevented if given with Misoprostol or as enteric-coated tablets).
  • Impaired hemostasis (prolonged bleeding—a small cut might bleed for a long time).
  • Allergy / Hypersensitivity reactions.
  • Hyperuricemia: At low doses, aspirin retains uric acid in the kidneys. (Clinical Trap: Giving low-dose aspirin to a patient with a history of Gout can trigger a massive gout attack!).
  • Decreased renal function.
  • Salicylism: A specific mild toxicity syndrome characterized by Vomiting, Tinnitus (severe ringing in ears), and Vertigo.
  • Respiratory depression in toxic doses (due to CNS effects and acid-base disturbances).
  • Reye's Syndrome: A fatal condition causing rapid brain and liver swelling in children recovering from viral illness (like chickenpox or the flu). Clinical Rule: Never give Aspirin to a child with a fever! Use Acetaminophen or Ibuprofen instead.

Contraindications:

  • Peptic ulcer disease.
  • Hemophilia or bleeding disorders.
  • Hypersensitivity.
  • Children with a viral illness.
  • Chronic liver disease.
  • Surgical Note: Aspirin must be stopped one week before elective surgery (because platelets take 7 days to regenerate).
  • Avoid high doses in G-6-PD deficient patients.
  • Pregnancy & Lactation: Avoid! Can cause rare but serious kidney problems in unborn babies and premature closure of the ductus arteriosus.

Note: There is NO specific chemical antidote for Aspirin overdose till date (treatment is supportive, largely involving alkalinizing the urine with sodium bicarbonate to trap the acid in the urine and force excretion).

B. ACETAMINOPHEN (Paracetamol)

MOA: Rapid absorption from GIT. Significant first-pass metabolism in gut wall and liver. It works mainly centrally (CNS) on COX-3.

Uses: Used for mild to moderate pain and fever.

Exam Trap: Acetaminophen has NO anti-inflammatory activity. It is NOT an NSAID. It will not reduce swelling in a sprained ankle or an arthritic knee.

Acetaminophen Toxicity & Overdose

At therapeutic doses, it is incredibly safe (may cause rare drug fever or mild increase in hepatic enzymes). However, in overdose (above 10-15g), the liver's normal metabolic pathways are totally overwhelmed. A minor pathway takes over, producing a highly toxic, tissue-destroying metabolite called NAPQI.

Overdose Symptoms: Hepatic necrosis (fatal liver failure), Renal tubular necrosis, Hypoglycemic coma.

The Antidote: N-acetyl Cysteine (NAC). Normally, the liver uses a substance called Glutathione to neutralize NAPQI. In overdose, glutathione runs out. NAC works by rapidly replenishing the liver's glutathione stores, neutralizing the toxic metabolite and saving the patient's liver.

C. SELECTIVE COX-2 INHIBITORS (The "Coxibs")

These drugs were engineered to be 10-20 times more selective for COX-2 and bind reversibly. The goal? Kill the pain/inflammation (by blocking COX-2) without hurting the stomach (by leaving COX-1 alone).

  • Celecoxib: Chemically a sulphonamide (watch for sulfa allergies!). Half-life of 11 hours.
  • Meloxicam: Related to Piroxicam. Preferentially selective.
  • Etoricoxib: Long half-life (22 hours). Requires strict monitoring of hepatic functions.
  • Nimesulide: Newer compound, less gastric irritation.

The "Coxib" Double-Edged Sword

The Advantages: Excellent analgesic, antipyretic, and anti-inflammatory effects. No inhibition of protective gastric PGs (No gastric irritation/ulcers). No inhibition of platelets (Does not prolong bleeding time).

The Disadvantages (The Fatal Flaw): High COX-2 selectivity ruins the delicate balance in the blood vessels. Normally, there is a "tug-of-war" between COX-2 (makes Prostacyclin, which dilates vessels and stops clots) and COX-1 (makes Thromboxane A2, which constricts vessels and makes platelets stick together).

By wiping out COX-2 completely, you leave COX-1 completely unopposed. The blood vessels clamp down and platelets clump together. Result: High risk of severe Cardiovascular thrombotic events (Myocardial Infarction / Strokes).

Historical Note: Drugs like Valdecoxib and Rofecoxib (Vioxx) were completely withdrawn from the market due to causing deadly heart attacks.

Other Adverse Effects: Renal toxicities (similar to non-selective NSAIDs) and Skin Rashes (specifically with Celecoxib due to its sulfa structure).


5. Master Clinical Uses Table (By Drug)

Memorize these specific associations based on your slides.

Generic NameTrade NameSpecific Clinical UsesSpecific Adverse Reactions
CelecoxibZycelRheumatoid arthritis (RA), Osteoarthritis (OA).Ophthalmic changes, Skin rashes, CV risk.
Diclofenac SodiumVoltaren, OlfenRA, OA, Ankylosing spondylitis.Gastric and duodenal ulcers formation, GI bleeding.
FenoprofenNalfonLong term management for mild to moderate pain.Visual disturbances, Jaundice, Peptic ulcers.
IbuprofenAdvil, IbumexMild to moderate pain, Painful dysmenorrhea, RA.GI Disturbances, Nausea, Dizziness, GI Bleeding.
IndomethacinIndocinRA, Ankylosing spondylitis, Acute gouty arthritis.Hematologic changes, Nausea, Constipation, Duodenal Ulcers.
MeflofenamateMeftalMild to moderate pain, Painful dysmenorrhea.Rash, Bleeding, Headache, Dizziness, Nausea, Dyspepsia.
NaproxenAleve, AnaproxManagement of inflammatory disorders, Mild/mod pain, Dysmenorrhea.Visual changes, Nausea, Vomiting, GI bleeding.
RofecoxibVioxxSigns/symptoms of OA, Acute pain, Primary dysmenorrhea. (Withdrawn)Visual Disturbances, CV events.
SulindacClinorilMild to moderate pain, RA, Ankylosing spondylitis, Gouty arthritis.Nausea, Vomiting, Diarrhea, Constipation, GI bleeding, Ulcers.
ValdecoxibBextraOA, RA. (Withdrawn)Anemia, Headache, Dyspepsia, CV events.

Choosing an NSAID (Advantages vs Disadvantages)

  • Salicylates (Aspirin):
    Advantage: Low cost, long history of safety.
    Disadvantage: Upper GI disturbances are very common.
  • Indoleacetic acids (Indomethacin/Sulindac) & Oxicams (Piroxicam):
    Advantage: Long half-life permits convenient daily or twice daily dosing.
    Disadvantage: Very potent; should only be used after less toxic agents fail. CNS disturbances are common.
  • Propionic acids (Ibuprofen, Naproxen, Ketoprofen):
    Advantage: Lower toxicity and better acceptance in some patients. Less GI irritation than Aspirin.

6. Crucial NSAID Contraindications & Drug Interactions

  • Absolute Contraindications: Known hypersensitivity, Third trimester of pregnancy (causes premature closure of fetal heart vessels - the ductus arteriosus), and during lactation.
  • Cross Sensitivity: If a patient is allergic to ONE NSAID, there is a high increased risk of an allergic reaction with ANY OTHER NSAID.
  • Use Cautiously In: Patients with bleeding disorders, renal disease, cardiovascular disease, or hepatic impairment.
  • The Elderly: Highly increased risk of severe Ulcers and fatal GI bleeds in patients age 65 and above.

Drug-Drug Interactions:

  • Anticoagulants (Warfarin): NSAIDs prolong bleeding time and drastically increase the bleeding effects of anticoagulants. (Clinical Scenario: An elderly man on Warfarin for atrial fibrillation takes over-the-counter Ibuprofen for knee pain. A week later, he presents to the ER vomiting blood due to a massive, uncontrollable GI bleed).
  • Diuretics & Antihypertensives: NSAIDs decrease the efficacy of blood pressure medications. (Clinical scenario: A patient on BP meds starts taking Ibuprofen daily for arthritis, and suddenly their blood pressure spikes out of control because the NSAID is retaining water and constricting renal vessels).
  • The "Triple Whammy" (Kidney Death): A classic fatal interaction is a patient taking an ACE Inhibitor + a Diuretic + an NSAID simultaneously. The diuretic drops blood volume, the ACEi dilates the efferent arteriole, and the NSAID clamps the afferent arteriole. The kidney's filtration pressure drops to absolute zero, causing sudden Acute Renal Failure.

7. Therapeutic Uses of Prostanoids and Analogues

While NSAIDs block prostanoids, sometimes in medicine, we actually want to give the patient synthetic prostanoids to achieve a specific physiological effect.

A. Obstetrics and Gynecology

PGE2 and PGF2α cause powerful uterine contractions.

  • First Trimester Abortion: Misoprostol (PGE1) given orally alongside Mifepristone or Methotrexate in the first few weeks. It causes softening of the cervix and uterine contraction leading to expulsion of uterine contents.
  • Second Trimester (Mid-Term) Abortion: Dinoprost (PGF2α) or Carboprost (given via intra-amniotic injection). Note: Carboprost is least used for this now due to severe side effects like anaphylactic shock and cardiovascular (CVS) collapse.
  • Facilitation of Labour & Cervical Priming: Dinoprostone (PGE2) is used vaginally for ripening the cervix and inducing labor at full term. Gemeprost / Demeprost / Denoproste are used vaginally for cervical priming in early pregnancy.
  • Postpartum Haemorrhage (PPH): Carboprost (IM) is powerfully effective at violently contracting the uterus to clamp down on bleeding vessels and control hemorrhage after birth.

Exam Trap: Oxytocin is the Drug of Choice (DOC) for labor induction. Prostaglandins are ONLY used when Oxytocin is contraindicated (e.g., renal failure, pre-eclampsia, eclampsia). The major advantage of PGs is that they do not cause Na+ and water retention (unlike oxytocin). Side effect of PGs here: prolonged bleeding.

B. Gastrointestinal System
  • Healing of Peptic Ulcers (PGE2, PGI2): Misoprostol (Oral, 200μg QD) binds to PG receptors on the parietal cell, decreasing intracellular cAMP, which decreases the activity of the proton pump (↓ Acid secretion - anti-ulcerogenic). It also ↑ Mucous & bicarbonate production to protect stomach lining, and ↑ Mucosal blood flow.
  • Enoprostil is specifically used for NSAID-induced ulcers and ulcers in chronic smokers. (Side effect of Misoprostol/Enoprostil: Severe GIT discomfort and profound diarrhoea due to increased gut motility).
  • Chronic Constipation: Lubiprostone. It works by activating type 2 chloride channels in the intestinal epithelial cells. This promotes secretion of Cl-, followed by passive secretion of Na+ and water, increasing stomach content liquidity. It also stimulates smooth muscle contraction to facilitate stool passage.
C. Cardiovascular System & Blood
  • To Prevent Platelet Aggregation: Epoprostenol (PGI2) is used in renal dialysis machines to prevent blood from clotting in the tubes.
  • Pulmonary Arterial Hypertension: Epoprostenol and Treprostinil (IV infusion). PGI2 lowers peripheral pulmonary and coronary resistance. They increase production of cAMP → decreases levels of intracellular Ca++ → causes vascular smooth muscle to relax (vessel dilation).
  • Peripheral Vascular Disease: Beraprost (Oral PGI2 given thrice a day).
  • Myocardial Infarction: Iloprost (IM) decreases infarct size when given after an MI.
  • Patency of Ductus Arteriosus (PDA): In neonates born with a fatal congenital heart disease (like Transposition of the Great Arteries), the ductus arteriosus must be kept open until emergency surgery can be performed to allow blood to mix. Alprostadil (PGE1) or Epoprostenol (PGI2) IV infusion is used. Side effect: maintaining patency for a long time leads to ductus fragility and rupture.
D. Other Specific Uses
  • Treating Open Angle Glaucoma: Latanoprost (PGF2α analog), Bimatoprost, Travoprost, Unoprostone (Topical drops). They physically increase the outflow of aqueous fluid from the eye via the uveoscleral pathway, relieving intraocular pressure.
  • Key Side Effect: Bimatoprost causes elongation of eye lashes (hypertrichosis - excessive hair growth anywhere on the body). (Clinical Fun Fact: This "side effect" is now sold commercially as the cosmetic drug Latisse to grow long eyelashes!).
  • Male Impotence (Erectile Dysfunction): Alprostadil (PGE1) via intra-cavernosal injection. Increases cAMP → ↓Ca++ → relaxes the trabecular smooth muscle and dilates cavernosal arteries, allowing blood to rush in and improving erection.
  • Bronchial Asthma: Prostanoids can cause bronchodilation, but they carry a prominent cough side effect, so they are rarely preferred over standard beta-agonists.

Summary: Side Effects of Prostanoids

Prostaglandins exhibit highly dose-related adverse effects because they are intense, natural inflammatory mediators. Giving them systemically effectively gives the patient full-body inflammation symptoms:

  • General: Bronchoconstriction, Hypotension, Vomiting, Diarrhoea, Fever, Dizziness, and Flushing.
  • Carboprost (Intra-amniotic): Can cause extreme anaphylactic shock and CVS collapse.
  • Alprostadil: Ductus fragility and rupture (if used too long in neonates).
  • Misoprostol / Enoprostil: Severe GIT discomfort and diarrhea.
  • PGE (Acting on EP4 receptors): Stimulates osteoclast and osteoblast activity, breaking down bone and inducing hypercalciuria (excess calcium in urine).

Advertisements

Error: Exam no longer exists or is unlisted.

Advertisements

NSAIDs & Prostanoids Read More »

Eicosanoids Pharmacology

Eicosanoids Pharmacology

Eicosanoids Pharmacology

Autocoids -- Eicosanoids


1. Introduction to Eicosanoids

Definition: Eicosanoids are biological signaling molecules (local hormones/autacoids) that are products of polyunsaturated long-chain fatty acids. The prefix "Eicosa-" means 20 in Greek, because these molecules are almost entirely derived from 20-carbon essential fatty acids, most commonly Arachidonic Acid.

Hormones vs. Eicosanoids (The "Global Email" vs. "Sticky Note" Analogy)

Unlike regular hormones (like insulin) which are stored in glands and travel globally through the blood, eicosanoids are not stored. They are highly unstable and have a half-life of seconds to minutes. Therefore, they are synthesized on demand from cell membrane lipids and act locally right where they are made (paracrine action on neighbors, or autocrine action on themselves).

Major Classifications

Eicosanoids are divided into families based on the specific enzyme that creates them from the raw material:

  • a) Cyclooxygenase (COX) derivatives: These include the Prostaglandins (PGs) and Thromboxane (TXA 2).
  • b) Lipoxygenase (LOX) products: These include the Leukotrienes (LTs) and Lipoxins.
  • c) Cytochrome P450 (CYP) Epoxyoxygenase pathway: Produces EETs (Epoxyeicosatrienoic acids).

2. The Synthesis Cascade (The Arachidonic Acid Pathway)

To understand the drugs, you MUST understand how eicosanoids are made. Picture a cell membrane. The lipids in that membrane hold the raw material (Arachidonic Acid) locked away safely.

STEP 1: THE RELEASE

Cell Membrane Phospholipids (Diacylglycerol or Phospholipid)
↓ Enzyme: Phospholipase A 2 (PLA 2) (or Phospholipase C)
Arachidonic Acid (Free and active)

Exam Gold: The Corticosteroid Blockade

Exam Note: Corticosteroids (like Prednisone or Dexamethasone) stimulate the production of a protein called Annexin A1 (also known as Lipocortin-1), which completely blocks Phospholipase A 2. This shuts down the ENTIRE cascade right at the top. No Arachidonic Acid means no prostaglandins and no leukotrienes. This is exactly why steroids are such incredibly powerful, broad-spectrum anti-inflammatories compared to NSAIDs!

Once Arachidonic Acid is free, it acts as a crossroads and can go down one of three enzymatic paths:

Path A: The COX Pathway

Arachidonic Acid + COX-1 or COX-2 (PGH 2 Synthase / Peroxidase) → PGG 2 → Prostaglandin H 2 (PGH 2).

PGH 2 is the unstable "parent" molecule. Depending on the specific tissue enzymes present, PGH 2 becomes:

  • Prostaglandins: PGE 2, PGF 2α, PGD 2.
  • Prostacyclin (PGI 2): Synthesized via Prostacyclin synthase (primarily in vascular endothelium).
  • Thromboxane (TXA 2): Synthesized via Thromboxane synthase (primarily in platelets).
Path B: The LOX Pathway

Arachidonic Acid + 5-LOX (Lipooxygenase + FLAP protein) → 5-HPETE.

5-HPETE becomes:

  • Leukotrienes: LTA 4 → LTB 4, LTC 4, LTD 4, LTE 4.
  • HETEs: (e.g., 8-HETE, 12-HETE, 15-HETE) - play crucial roles in inflammation and immune cell recruitment.
Path C: Cytochrome P450 Pathway

Arachidonic Acid + CYP Epoxygenases → EETs.

These play a role in maintaining vascular tone (vasodilation), renal function, and overall cardiovascular protection.


3. Mechanism of Action and Receptors

Eicosanoids do not enter cells. They bind to cell surface receptors that are all coupled to G-proteins (GPCRs).

Crucial Second Messenger Mechanisms

You must know whether they cause relaxation or contraction at the cellular level (tying back to your signaling lectures!):

  • Relaxers (PGI 2 and PGE 2): Link to Gs proteins. Increase Adenylyl Cyclase → Increases cAMP → Decreases intracellular Calcium (Ca++). Result: Smooth muscle relaxation and Vasodilation.
  • Contractors (TXA 2, PGF 2α): Link to Gq proteins. Activate Phospholipase C → Increases IP 3 → Increases intracellular Calcium (Ca++). Result: Smooth muscle contraction, Vasoconstriction, and Platelet Aggregation.

4. Physiological & Pharmacologic Effects by System

This is where the exam will test your clinical application. Memorize these specific receptor actions:

A. The Vasculature (Blood Vessels)

  • PGEs (PGE 1, PGE 2): Potent vasodilators.
  • Prostacyclin (PGI 2): Potent vasodilator. Can produce profound hypotension (low blood pressure).
  • Thromboxane A 2 (TXA 2): Potent vasoconstrictor.
  • Leukotrienes (LTC 4, LTD 4): Cause massive capillary leakiness (vascular permeability), contributing heavily to the swelling (edema) seen in severe inflammation.
  • **Alprostadil (PGE 1): Specifically dilates the ductus arteriosus in neonates.

B. Platelets (The Blood Clotting Tug-of-War)

There is a constant balance (a "see-saw") in your blood between two eicosanoids to prevent you from bleeding out or forming fatal clots:

  • Prostacyclin (PGI 2): Produced by healthy blood vessel walls. It INHIBITS platelet aggregation. (Mnemonic: Prostacyclin keeps blood CYCLING smoothly).
  • Thromboxane A 2 (TXA 2): Produced by platelets. It is a massive platelet activator/aggregator. (Mnemonic: Thromboxane causes THROMBI / clots).

Inflammation (Leukocytes): LTB 4 is a powerful chemotactic agent (it acts as a chemical beacon, attracting eosinophils, monocytes, and neutrophils to the site of injury). Conversely, prostaglandins generally inhibit cellular and humoral immunity to keep the immune system from overreacting.

C. The Lungs (Bronchial Tone)

  • Prostaglandins: Have mixed effects on bronchial muscle (PGE 1/PGE 2 cause bronchodilation, PGD 2/PGF 2α cause constriction).
  • TXA 2: Causes bronchoconstriction. Inhibitors of thromboxane will therefore reduce the bronchoconstrictive response.
  • Leukotrienes (LTC 4, LTD 4): Extremely potent bronchoconstrictors. These are the main culprits in deadly asthma attacks!

D. The Uterus (Obstetrics)

  • PGE 2 and PGF 2α: Cause powerful uterine contractions, especially in a pregnant uterus.
  • Clinical Tie-In (Dysmenorrhea): Overproduction of PGE 2 and PGF 2α during menstruation causes severe uterine cramping (primary dysmenorrhea). This is why taking an NSAID (which blocks these prostaglandins) cures menstrual cramps!
  • Clinically, synthetic versions are used as abortifacients (to induce medical abortions) or to induce labor at term.

E. Gastrointestinal Tract (GIT)

  • PGEs and PGI 2: Inhibit gastric acid secretion (which is normally stimulated by feeding, histamine, or gastrin).
  • They act as a shield, promoting the maintenance of the gastric mucosa by stimulating heavy mucus and bicarbonate secretion.
  • Clinical Tie-In: This is exactly why taking NSAIDs (which block PGE production) causes stomach ulcers! You strip away the stomach's protective mucus shield.

F. The Kidneys

  • PGE 2 and PGI 2: Cause renal vasodilation (specifically of the afferent arteriole), increase Renal Blood Flow (RBF), increase GFR, and promote diuresis (water excretion). (If a patient takes too many NSAIDs, they lose this vasodilation, the kidney starves of blood, leading to Acute Kidney Injury).
  • TXA 2: Causes renal vasoconstriction and has an ADH-like action (retains water).

G. Central Nervous System (CNS) & Eye

  • CNS: PGE 2 is the primary mediator of Fever, Pain perception, and Sleep. When a virus attacks you, the brain generates PGE 2 to reset the hypothalamus thermostat, causing fever.
  • Eye: PGF 2α regulates the outflow of aqueous humor.

5. Clinical Pharmacology: Uses of Prostanoids and Analogues

In pharmacology, we create synthetic versions (analogs) of these molecules to treat diseases.
Mnemonic trick: If a drug name ends in "-prost" or has "prost" in the middle, it is a prostaglandin analog!

Group 1: Prostaglandin E 1 (PGE 1) Analogs

Drug NameClinical Application & Mechanism
Alprostadil
(IV infusion, IV inj, Intracavernosal)
1. Patency of Ductus Arteriosus: Given to neonates born with severe congenital heart disease (e.g., Transposition of the Great Arteries) to keep the ductus arteriosus open, allowing oxygenated blood to mix until surgery can be performed. Side effect: Long-term use leads to ductus fragility and rupture.

2. Male Impotence: Injected directly into the penis. Increases cAMP → decreases Ca++ → relaxes trabecular smooth muscle and dilates cavernosal arteries, enhancing penile erection.
Misoprostol
(Oral)
1. Peptic Ulcers: Binds to PG receptors on parietal cells → decreases cAMP → inhibits proton pump → decreases acid secretion. It also increases mucous/bicarbonate and mucosal blood flow. Used specifically for NSAID-induced ulcers. Dose: 200μg QD.

2. Obstetrics (1st Trimester Abortion): Given orally with Mifepristone or Methotrexate in the first few weeks to soften the cervix and cause uterine contractions, expelling contents.

*Side Effects: Severe GIT discomfort and diarrhea.
Lubiprostone
(Oral)
Chronic Constipation: Activates Type 2 Chloride (Cl-) channels in intestinal epithelial cells. Cl- is secreted into the gut, followed passively by Na+ and water. This increases stomach content liquidity and stimulates smooth muscle passage of stool.

*Note: Enoprostil is another PGE 1 analog used similarly to Misoprostol for NSAID ulcers/chronic smokers.

Group 2: Prostaglandin F 2α (PGF 2α) Analogs

Drug NameClinical Application & Mechanism
Latanoprost, Bimatoprost, Travoprost, Unoprostone
(Topical Eye Drops)
Treating Open-Angle Glaucoma: These agents increase the outflow of aqueous fluid via the uveoscleral pathway, drastically lowering intraocular pressure.

*Key Side Effect (Exam Gold): Bimatoprost causes dramatic elongation, thickening, and darkening of eyelashes (hypertrichosis). This "side effect" is now used commercially (as the drug Latisse) to treat eyelash thinning!
Carboprost
(IM, Intra-amniotic)
1. Post-partum Hemorrhage (PPH): Highly effective at violently contracting the uterus to clamp down on bleeding vessels after birth.

2. Mid-Trimester Abortion: Intra-amniotic injection. Least used for this now due to severe side effects.

*Key Side Effect: Can cause severe anaphylactic shock and CVS (cardiovascular) collapse.
Dinoprost
(Intra-amniotic inj)
Mid-trimester (2nd Trimester) Abortion.

Group 3: Prostaglandin E 2 (PGE 2) Analogs

Drug NameClinical Application & Mechanism
Dinoprostone
(Vaginal tab/gel/pessary)
Induction of Labour & Cervical Ripening: Used vaginally at full term to induce labor (improves the "Bishop score" by physically softening the cervix).
*Note: Oxytocin is usually the Drug of Choice (DOC) for labor induction. PGs are only used when Oxytocin is contraindicated (e.g., Renal failure, Pre-eclampsia, Eclampsia) because PGs do not cause Na+/water retention like oxytocin does.

Also used for Mid-Term Abortion.
*Side Effect: Prolonged bleeding.
Gemeprost / Demeprost / Denoproste
(Vaginal pessary)
Used vaginally for cervical priming in early pregnancy.

Group 4: Prostacyclin (PGI 2) Analogs

Drug NameClinical Application & Mechanism
Epoprostenol & Treprostinil
(IV Infusion)
1. Pulmonary Arterial Hypertension: Lowers peripheral pulmonary and coronary resistance. They increase cAMP → decrease Ca++ → cause profound pulmonary vessel dilation, taking the strain off the right side of the heart.

2. Renal Dialysis: Used to inhibit platelet aggregation so blood doesn't clot in the dialysis machine.
Beraprost
(Oral)
Used for Peripheral Vascular Disease (given orally, thrice a day) to dilate vessels in the legs.
Iloprost
(IM)
Decreases infarct size when given IM after a Myocardial Infarction (MI).

6. Clinical Uses of Eicosanoid Blockers

By blocking the synthesis pathways, we can treat various inflammatory and allergic conditions.

A. Asthma Management
  • Leukotriene Receptor Antagonists: Zafirlukast, Montelukast. They block the LTD 4 receptors in the lungs, preventing bronchoconstriction.
  • Lipoxygenase (LOX) Inhibitors: Zileuton. Stops the synthesis of leukotrienes entirely.

Clinical Scenario: If you give an asthmatic patient Aspirin, it blocks the COX pathway. The built-up Arachidonic acid has nowhere to go, so it is all "shunted" down the LOX pathway, creating massive amounts of Leukotrienes. This triggers a deadly asthma attack known as Aspirin-Exacerbated Respiratory Disease (AERD).

B. Anti-inflammatory & Analgesia
  • NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Block Cyclooxygenase (COX-1 and COX-2), preventing the creation of pain/fever-inducing prostaglandins. Used for Rheumatoid arthritis and Dysmenorrhea (menstrual cramps).
C. Antiplatelet Action
  • Aspirin (Low Dose): Aspirin irreversibly inhibits COX. At low doses (e.g., 81mg), it is highly selective for blocking TXA 2 in platelets (stopping clots) without totally destroying the protective PGI 2 in blood vessels. Because platelets do not have a nucleus, they cannot make new COX enzymes. The anti-clotting effect lasts for the entire lifespan of the platelet (7-10 days)!

7. Selective COX-2 Inhibitors (The "Coxibs")

Traditional NSAIDs (like Ibuprofen) block both COX-1 (which makes stomach-protecting mucus) and COX-2 (which makes inflammatory pain molecules). This causes stomach ulcers. Selective COX-2 Inhibitors were developed to be 10-20 times more selective for COX-2, aiming to stop pain without hurting the stomach. They are reversible inhibitors.

  • Celecoxib: Chemically a sulfonamide. Half-life of 11 hours.
  • Meloxicam: Related to Piroxicam. Preferentially selective COX-2 inhibitor.
  • Etoricoxib: Long half-life (22 hours). Requires strict monitoring of hepatic (liver) functions.
  • Nimesulide: A newer compound causing less gastric irritation.

Advantages of COX-2 Inhibitors:

  • Excellent Analgesic, Antipyretic (reduces fever), and Anti-inflammatory effects.
  • NO inhibition of protective gastric PGs = No gastric irritation/ulcers!
  • NO inhibition of platelet aggregation = Does NOT prolong bleeding time (making them safer before surgeries).

The Massive Disadvantage / Adverse Effects (The Vioxx Disaster)

Drugs like Valdecoxib and Rofecoxib (Vioxx) were completely WITHDRAWN from the market. Why?

Because COX-2 usually makes Prostacyclin (PGI 2) which stops clots, while COX-1 makes Thromboxane (TXA 2) which causes clots. If you selectively block ONLY COX-2, you eliminate the anti-clotting mechanism, leaving TXA 2 completely unopposed. This led to a massively higher risk of Cardiovascular thrombotic events (Myocardial Infarction / Heart Attacks and Strokes) in patients taking these drugs.


Other Side Effects: Renal toxicities (kidney damage) are exactly similar to non-selective NSAIDs. Celecoxib specifically can cause Skin Rashes (because it contains a sulfa group, triggering sulfa allergies).


8. Summary: Side Effects of Prostanoids

When giving synthetic prostanoids to a patient, you are basically causing a systemic inflammatory response. Effects are highly dose-related:

  • Systemic: Hypotension, fever, dizziness, flushing.
  • Respiratory: Bronchoconstriction (Cough is a notable side effect when using bronchodilators for asthma).
  • GI tract: Vomiting, severe diarrhea (especially Misoprostol and Enoprostil).
  • Severe reactions: Carboprost (anaphylactic shock, CVS collapse).
  • Neonatal: Alprostadil over-usage causes ductus fragility and rupture.
  • Bone/Kidney: PGE acting on EP4 receptors can increase osteoclast/osteoblast activity, inducing hypercalciuria (excess calcium in urine).

Advertisements

Quick Quiz

Paediatrics i Day 1 Quiz

Paediatrics

Privacy: Your details are used only for quiz tracking and certificates.

Advertisements

Eicosanoids Pharmacology Read More »

Serotonin Pharmacology

Serotonin Pharmacology

Serotonin Pharmacology

Autocoids -- Serotonin

Serotonin & Migraine Pharmacology


1. Brief Recap: What are Autacoids?

Before diving into Serotonin, remember the baseline definition from the start of the lecture. Autacoids are the body's local communication network.

  • Definition: Endogenous substances (made in the body) that act as biological factors or "local hormones". (Greek: Autos = self, Akos = remedy).
  • Characteristics: Present in very small amounts, have distinct biological activity, are short-living with a short duration of action, and act at or very close to their site of release.
  • Systemic Effect: Although they are "local", if produced in massive amounts, they can enter the circulation and cause whole-body (systemic) effects.
  • Functions: They regulate physiological baselines, mediate pathophysiological reactions to injuries (like inflammation), and modulate nerve transmission.
Analogy

Endocrine Hormones vs. Autacoids

Think of standard Endocrine Hormones (like insulin or thyroid hormone) as a company-wide email broadcast. They travel through the main server (the bloodstream) to reach every department in the body. In contrast, Autacoids are like sticky notes left on a coworker's desk. They are meant only for the immediate neighbor (local action) and are thrown away quickly (short duration of action).

Chemical Classification of Autacoids

Autacoids are classified into four main families based on their chemical structure:

1. Amines

Histamine, Serotonin (5-HT).

2. Polypeptides

Kinins, Oxytocin, Angiotensin, Vasopressin, Endothelins.

3. Fatty Acids

Prostaglandins, Leukotrienes, Thromboxanes, PAF (Platelet Activating Factor).

4. Others

Nitric Oxide (NO), Cytokines.


2. Serotonin (5-HT): Synthesis and Metabolism

Serotonin, chemically known as 5-hydroxytryptamine (5-HT), is an indoleethylamine. It is widely distributed in nature—found in plants (like bananas and pineapples), animal tissues, venoms, and insect stings.

A. The Synthesis Pathway

Serotonin is built from the amino acid L-tryptophan. This is a critical two-step process:

  1. L-Tryptophan
    ↓ (Enzyme: Tryptophan Hydroxylase) — *Rate Limiting Step*
  2. 5-Hydroxytryptophan (5-HTP)
    ↓ (Enzyme: Decarboxylase)
  3. 5-Hydroxytryptamine (Serotonin / 5-HT)
  • The Rate-Limiting Step: Hydroxylation at the C5 position is the bottleneck of the whole process. The body can only make Serotonin as fast as Tryptophan Hydroxylase works.
  • Experimental Blockers: You can chemically block this rate-limiting step using drugs like p-chlorophenylalanine (PCPA / fenclonine) and p-chloroamphetamine. Experimentally, these were used to reduce serotonin in carcinoid syndrome, but they are too toxic for clinical human use.

B. Inactivation and Metabolism

Once Serotonin does its job, it must be rapidly inactivated so it doesn't continuously overstimulate the body. It is metabolized primarily by the enzyme Monoamine Oxidase (MAO).

  • Serotonin (5-HT)
    ↓ (Enzyme: MAO)
  • 5-hydroxyindoleacetaldehyde
    ↓ (Enzyme: Aldehyde Dehydrogenase)
  • 5-HIAA (5-hydroxyindoleacetic acid) — *The Principal Metabolite*
Exam Trap!

The Carcinoid Tumor Diagnostic Test

Clinical Scenario: A patient presents with severe flushing, severe diarrhea, and right-sided heart valve issues. You suspect a Carcinoid Tumor (a rare gut tumor that secretes massive amounts of serotonin).

The Test: You measure the 24-hour urinary excretion of 5-HIAA (the final breakdown product). High 5-HIAA confirms massive serotonin synthesis.

The Trap: Before the test, you MUST prohibit the patient from eating foods rich in serotonin or tryptophan (e.g., Bananas, Pineapples, Plums). If they eat a bunch of bananas before the test, their body will metabolize that dietary serotonin, their urine 5-HIAA will skyrocket, giving a false positive for a tumor!

Clinical Scenario: MAO Inhibitors & Serotonin Syndrome

If a patient is taking a drug that blocks Monoamine Oxidase (an MAOI antidepressant like Phenelzine), the serotonin cannot be broken down. If this patient then takes another drug that increases serotonin (like an SSRI or MDMA/Ecstasy), serotonin builds up to lethal levels. This causes Serotonin Syndrome: hyperthermia, muscle rigidity, tremors, and potentially death.


3. Storage, Release, and Locations of 5-HT

Where is Serotonin found in Mammals?

  • The Gut (90%): Over 90% of all serotonin in the human body is located in the enterochromaffin cells of the gastrointestinal tract. (Deep Explanation: This is why SSRI antidepressants, which increase active serotonin everywhere, almost always cause GI upset, nausea, and diarrhea in the first week of use! The gut has far more serotonin receptors than the brain).
  • The Blood (Platelets): Serotonin floats in the blood stored safely inside platelets. Platelets don't make serotonin; they suck it up from the plasma using an active Serotonin Transporter (SERT). (Why? When you get cut, platelets clump together and release serotonin to cause local vasoconstriction, stopping the bleeding!).
  • The Central Nervous System (Nerve Endings): Found heavily in the raphe nuclei of the brainstem. These neurons synthesize, store, and release 5-HT as a true neurotransmitter controlling mood and sleep.
  • The Pineal Gland: Here, serotonin serves as a precursor. An enzyme (Hydroxyindole-O-methyltransferase) converts serotonin into Melatonin, the hormone that induces sleep.

How is it Stored?

Whether in a nerve ending or a platelet, serotonin is pumped into protective storage vesicles by a pump called the Vesicle-Associated Transporter (VAT).

Pharmacological Blockade: The drug Reserpine completely blocks VAT. If serotonin cannot get into the protective vesicle, it is left out in the open and is destroyed by MAO in the cytoplasm. Therefore, Reserpine severely depletes stored serotonin (just like it depletes catecholamines), which historically caused severe, suicidal depression in patients taking it for high blood pressure.


4. Physiological Actions of Serotonin

SystemSpecific Actions of 5-HT
Central Nervous System (CNS)Affects mood, sleep, appetite, temperature regulation, pain perception, blood pressure, and vomiting.
Deficiency: Causes depression, anxiety, migraines.
Neuroendocrine: Controls hypothalamic cells releasing anterior pituitary hormones.
Gastrointestinal (GI)Causes intense rhythmic contractions of the small intestines (via 5-HT4). Stimulates vomiting via the 5-HT3 receptors on vagal nerves.
Cardiovascular SystemPotent contraction of smooth muscle (via 5-HT2), causing constriction of veins. Exception: It does not contract skeletal muscle or heart muscle. Triggers Platelet aggregation (clotting) via 5-HT2.
Respiratory SystemCauses mild stimulation in healthy lungs, but triggers severe bronchoconstriction in asthmatics (via 5-HT2 in smooth muscles). (Explanation: Asthmatic airways are hyper-reactive to autacoids. Even a tiny bit of serotonin can trigger an asthma attack).

5. Serotonin Receptors (The Pharmacology Targets)

There are at least 15 types and subtypes of serotonin receptors. You must memorize the mechanisms of the main ones:

Crucial Mechanism Trap

Receptors 1 through 6 are all G-protein coupled receptors (GPCRs).
Receptor 5-HT3 is the ONLY exception! It is a Ligand-gated Na+/K+ ion channel. If an exam asks which receptor acts the fastest or doesn't use second messengers, the answer is always 5-HT3.

  • 5-HT1 (A-H): Found in CNS (usually inhibitory) and smooth muscles.
    • 5-HT1A: Role in Anxiety/Depression.
    • 5-HT1D / 1B: Role in Migraine (causes vasoconstriction when activated).
  • 5-HT2 (A-C): Found in CNS (usually excitatory). In the periphery, activation leads to vasodilation, contraction of bronchioles, GIT, uterine smooth muscle, and platelet aggregation.
  • 5-HT3: Found in the Area Postrema (the vomit center in the brain) and peripheral sensory/enteric nerves. Primary role: Nausea and Vomiting (especially from chemotherapy).
  • 5-HT4: Role in the management of irritable bowel syndrome (IBS) and constipation (stimulates GI motility).
  • 5-HT5 to 5-HT7: Novel targets for antidepressants and antipsychotics.

6. Serotonin Agonists & Migraine Management

Migraines are characterized by a variable duration involving nausea, vomiting, visual disturbances (auras), speech abnormalities, followed by a severe, throbbing headache.

Pathophysiology of a Migraine

  1. Involves the trigeminal nerve distribution to intracranial arteries.
  2. These nerves inappropriately release peptide neurotransmitters—especially Calcitonin Gene-Related Peptide (CGRP), which is an extremely powerful vasodilator. (Substance P and Neurokinin A are also involved).
  3. This causes massive vasodilation. Plasma and proteins leak out of the vessels, causing perivascular edema.
  4. This sudden swelling/edema stretches and activates pain nerve endings in the dura mater, causing the severe headache. (Deep Explanation: The headache is "throbbing" because the hyper-dilated blood vessels are physically pulsing against the stretched, sensitive nerves with every single heartbeat).

A. Acute Migraine Therapy: The Triptans (5-HT1D/1B Agonists)

Mechanism of Action: They have two hypothetical mechanisms:

  1. They activate 5-HT1D/1B receptors on presynaptic trigeminal nerve endings, which inhibits the release of vasodilating peptides (like CGRP).
  2. They act as direct vasoconstrictors, preventing the vasodilation and stretching of pain endings. By shrinking the blood vessel back down, it stops throbbing against the nerve.

Triptan Contraindications & Side Effects

Use: Acute severe migraine attacks (First-line therapy is Sumatriptan).

Side Effects: Tingling, warmth, dizziness, muscle weakness, neck pain. They can cause chest or throat pressure due to bronchospasms.

ABSOLUTE CONTRAINDICATION: Because Triptans heavily constrict blood vessels, they are strictly contraindicated in patients with Coronary Artery Disease (Angina) or previous heart attacks. Giving a triptan to someone with bad, clogged heart arteries can trigger a fatal myocardial infarction (heart attack)!

Pharmacokinetics of Triptans (Table 16-5)

You must know the basic routes and half-lives:

DrugRoutesTime to Onset (h)Half-Life (h)
AlmotriptanOral2.63.3
EletriptanOral24
FrovatriptanOral327 (Longest half-life by far!)
NaratriptanOral25.5
RizatriptanOral1 - 2.52
SumatriptanOral, nasal, Subcutaneous1.5 (0.2 for SubQ)2
ZolmitriptanOral, nasal1.5 - 32.8

B. Other Acute Migraine Drugs

  • Anti-inflammatory analgesics: Aspirin and Ibuprofen are helpful in controlling mild/moderate pain.
  • Antiemetics: For severe nausea and vomiting accompanying the migraine, parenteral Metoclopramide is highly helpful.
  • Ergot Alkaloids: (e.g., Ergotamine, Ergonovine). Act as partial agonists at 5-HT2, alpha, and other receptors. Cause severe vasoconstriction. Historical & Clinical Note

    Side effects of Ergots: Abortions (never give to pregnant women, it violently contracts the uterus), severe ischemia, and gangrene from prolonged vasoconstriction, GI distress. (Historically, consuming moldy rye bread infected with the ergot fungus caused "St. Anthony's Fire" — mass epidemics of people losing limbs to gangrene and hallucinating. This is suspected to have played a role in the Salem Witch Trials!)

C. Migraine Prophylaxis (Prevention)

These drugs do NOT stop an acute attack; they are taken daily to prevent recurrences:

  • Propranolol: Beta-blocker.
  • Amitriptyline: A Tricyclic Antidepressant (TCA) that blocks the reuptake of serotonin, used for neuropathic pain.
  • Valproic Acid & Topiramate: Anticonvulsants with good prophylactic efficacy.
  • Calcium Channel Blockers: Flunarizine is highly effective in trials. Verapamil has modest efficacy.

D. Other Serotonin Agonists

  • Buspirone: A partial 5-HT1A agonist used to treat Anxiety.
  • Fluoxetine (SSRI): A Selective Serotonin Reuptake Inhibitor. Keeps 5-HT in the synapse longer. Used for Depression.
  • LSD (Lysergic Acid Diethylamide): A 5-HT1A agonist. Used as an illicit drug of abuse; acts as a powerful hallucinogen.

7. Serotonin Antagonists (Blockers)

1. Methysergide and Cyproheptadine

Mechanism: Both are 5-HT1 and 5-HT2 antagonists.

  • Cyproheptadine is unique. It structurally resembles phenothiazine antihistamines. Therefore, it is a potent H1-receptor blocker AND a 5-HT2 blocker.
  • Actions: Prevents smooth muscle effects of both histamine and 5-HT. Has significant antimuscarinic effects (causes dry mouth) and causes strong sedation.
  • Clinical Use: Carcinoid tumor syndrome, other GI tumors, and cold-induced urticaria (hives).
    (Clinical Scenario: If a patient presents with Serotonin Syndrome from an antidepressant overdose, Cyproheptadine is the literal antidote because it aggressively blocks the 5-HT2 receptors!)

2. Atypical Antipsychotics (Receptors are in the CNS)

  • Olanzapine: A 5-HT2A antagonist with presynaptic effects. Used to decrease symptoms of psychosis and schizophrenia.
  • Clozapine: A 5-HT2A / 2C antagonist. Used for severe schizophrenia and psychosis.

3. Cardiovascular & Antiemetic Antagonists

  • Ketanserin: A 5-HT2 AND Alpha-1 antagonist. The alpha-blocking effect makes it a potent antihypertensive and useful for treating vasospasms.
  • Ondansetron: A pure 5-HT3 antagonist.
    • Mechanism: Blocks the activation of the 5-HT3 ion channel in the Area Postrema (Chemoreceptor Trigger Zone).
    • Clinical Use: The absolute gold standard for treating nausea and vomiting induced by Chemotherapy and Radiation, as well as post-operative nausea. (Deep Explanation: Chemotherapy drugs often damage the gut lining, causing enterochromaffin cells to dump massive amounts of serotonin. This serotonin hits the 5-HT3 receptors on the vagus nerve, sending a "vomit" signal to the brain. Ondansetron blocks this signal, revolutionizing cancer care by allowing patients to tolerate chemo!).

Advertisements

Quick Quiz

Medicine Day 9 Quiz

Medical Nursing

Privacy: Your details are used only for quiz tracking and certificates.

Advertisements

Serotonin Pharmacology Read More »

Histamine Pharmacology

Histamine Pharmacology

Histamine Pharmacology

Autocoids -- Histamine


1. Introduction to Autacoids


What is an Autacoid?

The term comes from the Greek words Autos (meaning "self") and Akos (meaning "medicinal agent" or "remedy"). Therefore, an autacoid is literally a "self-remedy."

By definition, Autacoids are endogenous substances (made naturally inside the body) that act as biological factors or "local hormones".

Exam Trap: Autacoids vs. Classic Hormones

A classic hormone (like insulin or thyroid hormone) is produced in a specific, centralized gland, dumped into the systemic bloodstream, and travels a long distance to reach its target organ.

Autacoids are DIFFERENT:

  • They are produced by widely distributed tissues all over the body, not a single gland.
  • They act locally (at or very close to their exact site of synthesis and release).
  • They are present in very small amounts.
  • They have a short lifespan with a very short duration of action (they are rapidly destroyed to prevent them from causing systemic chaos).

Note: However, if produced in massive, pathological amounts (like during severe anaphylactic shock), they can overcome local destruction, enter the systemic circulation, and have life-threatening systemic effects.

Classification & Examples of Autacoids

You must know the chemical classification of the different autacoids. Exam questions frequently mix these up:

Chemical ClassExamples
AminesHistamine, Serotonin (5-HT)
Polypeptides (Proteins)Kinins (Bradykinin), Oxytocin, Angiotensin, Vasopressin, Endothelins
Fatty Acids (Eicosanoids)Prostaglandins, Leukotrienes, Thromboxanes, Platelet Activating Factor (PAF)
OthersNitric Oxide (NO - Endothelium-derived relaxing factor), Cytokines

2. Histamine: Synthesis, Storage, and Metabolism

Histamine is a ubiquitous molecule. It is present everywhere: in bacteria, plants, animals, and notably in venoms and stinging fluids (like bee stings, wasp venom, or stinging nettle plants).

Chemistry & Synthesis

  • Chemistry: It is a basic amine, specifically a β-aminoethylimidazole.
  • Synthesis: The amino acid L-Histidine undergoes decarboxylation (the chemical removal of a CO 2 molecule) to become Histamine. The specific enzyme that performs this action is L-Histidine decarboxylase.

Inactivation & Metabolism

Because histamine is so incredibly potent, it must be deactivated rapidly if it isn't safely stored away. There are two major metabolic pathways the body uses to break it down and excrete it in the urine:

  1. Pathway 1 (Methylation): Conversion to N-methylhistamine (via the enzyme N-methyl transferase), which is then oxidized by MAO (Monoamine Oxidase) / DAO into methylimidazoleacetic acid.
  2. Pathway 2 (Oxidation): Direct conversion by the enzyme Diamine Oxidase (DAO) into imidazoleacetic acid (IAA).

3. Histamine Storage and Release Mechanisms

Where is histamine kept? In humans, it is mostly stored inside Mast Cells (found abundantly in tissues interfacing with the outside world like Skin, Lungs, and GI tract) and Basophils (circulating in the blood). Inside these cells, histamine is locked up in granules, tightly bound to a heparin-protein complex so it doesn't leak out.

Histamine can be released in two distinct ways: Immunologic (Antigen-mediated) and Non-Immunologic.

A. Immunologic Release (Antigen-Mediated)

This is the classic Type I Hypersensitivity (Immediate Allergic Reaction).

  • The Process: A person is exposed to an allergen (e.g., pollen, peanuts). Their immune system mistakenly creates IgE antibodies against it. These IgE antibodies attach to the surface of mast cells (a process called sensitizing the cell). Upon a second exposure to the same pollen, the allergen physically bridges and cross-links the IgE antibodies on the mast cell surface.
  • The Result: The mast cell degranulates "explosively", dumping massive amounts of histamine into the tissue. This specific process is energy-dependent (requires ATP) and requires calcium.
Crucial Physiological Concept

Negative Feedback & The Lung Exception

In skin mast cells and blood basophils, the released histamine eventually binds back onto its own H 2 receptors located on the mast cell's own surface. This acts as a biological "brakes" system, inhibiting further histamine release (Negative Feedback).

EXAM EXCEPTION: This feedback inhibition does NOT occur in lung mast cells! This is exactly why allergic asthma attacks in the lungs can spiral out of control so rapidly and become fatal; there are no built-in brakes to stop the continuous histamine release in the bronchioles.

B. Non-Antigen Mediated Release

This release mechanism does not require the immune system to be sensitized with IgE. It happens through direct physical or chemical interaction.

  1. Chemical Release: Certain drugs and chemicals can physically enter the mast cell and displace histamine from its heparin complex, forcing it out.
    • Examples: Morphine, Tubocurarine (neuromuscular blocker), radiocontrast media (used in CT scans), amides, alkaloids, and basic polypeptides (like wasp/bee venoms).
  2. Mechanical Release: Physical trauma forces the mast cells to burst open. Examples: Vigorous scratching of the skin, severe burns, or crushing injuries.
  3. Cellular Proliferation: Pathological overgrowth of cells naturally increases total body histamine levels simply because there are more cells making it. Examples: Leukemia, Gastric Carcinoid Tumors.
  4. Physical Stimuli: Extreme cold, excessive heat, or exposure to bacterial toxins.
Clinical Scenario

"Red Man Syndrome" & IV Morphine

The Event: If a nurse pushes an intravenous dose of Morphine too fast, the patient may suddenly flush bright red, feel intensely hot, become incredibly itchy, and their blood pressure might drop precipitously.

The Mechanism: This is frequently mistaken for an allergy. It is not a true allergy (no IgE is involved). The rapid bolus of morphine chemically displaced histamine from the patient's mast cells all at once, causing sudden, massive vasodilation. This is a classic example of Non-Antigen Mediated Chemical Release.

The Fix: Stop the infusion, administer an antihistamine (like Diphenhydramine), and when restarting, push the morphine much slower.


4. Sites of Histamine Action

Histamine regulates multiple physiological systems beyond just making you sneeze:

  • Mast Cells & Basophils: Triggers standard inflammation and allergy symptoms (Skin itching, Lung wheezing, GIT cramping).
  • Central Nervous System (CNS): Acts as a critical neurotransmitter, keeping the brain awake and alert.
  • Neuroendocrine: Regulates hormones. It stimulates the release of ACTH, Prolactin (PRL), Vasopressin (VP), Oxytocin, and LH. It inhibits the release of GH and TSH.
  • Thermal & Cardio: Causes hyperthermia (feverish feeling) via H 1/H 3 receptors located in the preoptic nucleus of the hypothalamus.
  • Body Weight & Sleep: Acts as a powerful appetite suppressant (via H 1), potentiates the hormone leptin (causing weight loss signaling), accelerates lipolysis (fat breakdown), and regulates sleep/arousal (keeps you awake).
  • Stomach: Released from entero-chromaffin-like (ECL) cells in the stomach wall. It is one of the primary secretagogues that activate parietal cells to pump out massive amounts of gastric acid.

5. Histamine Receptors & Their Effects

Histamine acts on four distinct receptors (H 1, H 2, H 3, H 4). ALL of them are G-Protein Coupled Receptors (GPCRs). Currently, clinical pharmacology heavily targets H 1 and H 2.

ReceptorLocation / DistributionPost-Receptor MechanismSelective Antagonists (Blockers)
H 1Smooth muscle (bronchi, gut), Endothelium, BrainG q → ↑ IP3, DAG → ↑ Intracellular Ca 2+Mepyramine, Cetirizine, Loratadine
H 2Gastric mucosa (parietal cells), Cardiac muscle, Mast cells, BrainG s → ↑ cAMPRanitidine, Cimetidine, Famotidine
H 3Presynaptic neurons (Brain, myenteric plexus)G i → ↓ cAMP, ↓ Ca 2+Thioperamide

A. H 1-Receptor Stimulation (The Allergy Receptor)

When histamine hits H 1 receptors, it causes severe, rapid inflammatory changes:

  • Endothelial Contraction: The endothelial cells lining venules actually shrink and pull apart, widening the gaps between them. This drastically increases vascular permeability, allowing protein-rich fluid to leak out into the tissues (this causes edema/swelling and a runny nose).
  • Smooth Muscle Contraction: Causes severe bronchoconstriction (asthma attack), intestinal cramps (diarrhea), and uterine contractions.
  • Vasodilation: Despite contracting the venules, it heavily dilates the arterioles. This causes the classic red flushing, severe headaches (vessels in the brain swelling), and a dangerous drop in blood pressure.
  • Nerve Endings: Stimulates superficial sensory nerves to cause Pain and intense Itching (Pruritus).
Exam Must-Know

The Triple Response of Lewis

If you take a dull instrument and firmly scratch a person's skin, histamine is released locally. This causes three distinct, highly predictable visual phases to appear on the skin:

  1. Flush (Red Spot): A localized red spot appears instantly along the scratch line due to direct capillary vasodilation.
  2. Weal (Swelling/Bump): The scratched area raises up and becomes puffy due to vascular leakage (edema) caused by endothelial contraction.
  3. Flare (Red Halo): A much wider, brighter red area spreads outwards surrounding the scratch. This is caused by indirect vasodilation (an axon reflex triggering nearby vessels to also dilate).

B. H 2-Receptor Stimulation (The Stomach Receptor)

  • Stomach: Activates Parietal Cells to massively secrete H+ (stomach acid). This is the major target for ulcer-healing drugs.
  • Heart: Increases the force of contraction (positive inotropy) and increases Heart Rate (positive chronotropy).
  • Blood Vessels: Causes vasodilation.

C. H 3-Receptor Stimulation (The Brain/Nerve Receptor)

H 3 receptors are mostly presynaptic (they sit on the nerve terminal that is releasing the chemical, acting as volume control knobs).

  • Autoreceptors: When histamine binds to an H 3 autoreceptor on a histamine-releasing neuron, it provides negative feedback, stopping the synthesis and release of more histamine.
  • Heteroreceptors: When histamine binds to H 3 receptors on *other* nerve types, it inhibits the release of other major neurotransmitters like GABA, Norepinephrine, Dopamine, Serotonin, and Acetylcholine.

Future Pharmacology: H 3 Agonists

Because H 3 receptors regulate brain chemistry so heavily, they are massive potential therapeutic targets for cognitive and psychiatric disorders such as Sleep disorders (Narcolepsy), Parkinson's disease, ADHD, and Schizophrenia.

Examples of H 3 Agonists:

  • α-methylhistamine
  • Cipralisant
  • Imbutamine (also an H 4 agonist)
  • Immepip
  • Imetit
  • Immethridine
  • Methimepip
  • Proxyfan

6. Pathological Reactions & Clinical Uses of Histamine

Pathology Mediated by Histamine

  • Type I Hypersensitivity: Hay fever, allergic rhinitis (itchy/watery eyes, sneezing), urticaria (hives from nettles or insect stings).
  • Anaphylactic Shock: Massive systemic histamine release causing severe hypotension (shock from vasodilation) and suffocation (from severe bronchoconstriction).
  • Emesis: Histamine mediates motion sickness pathways in the brain.
  • Peptic Ulcer Disease (PUD): Excessive H 2 stimulation causes an acid overload, eating through the protective stomach lining.

Clinical Uses of Pure Histamine

Doctors rarely give pure histamine as a treatment because it is highly uncomfortable and dangerous (it causes shock and asthma). However, it has one specific diagnostic use:

Diagnostic Positive Control: It is used as a positive control injection during allergy skin testing. If a doctor is trying to see what you are allergic to, they will prick your back with 20 different allergens. They will also prick you with pure histamine. If the pure histamine prick doesn't produce a Weal and Flare, it means either your immune system is completely unresponsive, or you cheated and took an antihistamine pill before the test, rendering the entire allergy test invalid.


7. Antagonists (The "Antihistamines")

A. H 1 Antagonists (Allergy & Cold Meds)

These drugs competitively block histamine from binding to H 1 receptors. They reliably relieve sneezing, itchy eyes, runny nose, and hives. They are also used for allergies, motion sickness, vertigo, and insomnia.

They are divided into two distinct generations based heavily on their ability to cross the Blood-Brain Barrier (BBB).

1st Generation

The Sedating Ones

These are lipophilic, cross the BBB easily, block H 1 in the brain (causing profound sleepiness), and often lack specificity (they also block muscarinic receptors, causing dry mouth, blurred vision, and urinary retention).

  • Highly Sedative & Potent: Promethazine, Hydroxyzine, Diphenhydramine, Dimenhydrinate (great for motion sickness).
  • Moderately Sedative: Pheniramine, Cinnarizine, Meclizine, Buclizine, Cyproheptadine (unique because it also stimulates appetite).
  • Mild/Less Sedative: Chlorpheniramine, Dexchlorpheniramine, Clemastine, Mebhydroline, Dimethindone.
2nd Generation

The Non-Sedating Ones

These are bulky or ionized molecules that do not cross the BBB well. They are mainly pure anti-allergics with little to no sleepiness and fewer muscarinic side effects.

  • Examples: Cetirizine, Levocetirizine, Loratadine, Desloratadine, Fexofenadine, Azelastine, Ebastine, Mizolastine, Rupatadine.

Clinical Application of H 1 Blockers

The Truck Driver: If a commercial truck driver has bad seasonal allergies, you MUST NOT prescribe Diphenhydramine (1st gen), or he will fall asleep at the wheel and crash. You must prescribe Loratadine or Fexofenadine (2nd gen).

The Itchy Sleepless Patient: Conversely, if a patient cannot sleep because they are covered in an incredibly itchy poison ivy rash, Diphenhydramine is the absolutely perfect drug because it cures the itch *and* utilizes its sedative side effect to help them sleep.

For Vertigo/Migraines: Flunarizine and Cinnarizine are specifically noted for having excellent antivertigo and antimigraine properties by regulating inner ear fluid and blood flow.

B. H 2 Antagonists (The Acid Blockers)

H 2 blockers profoundly reduce stomach acid production by competitively blocking histamine at the H 2 receptors on the stomach's parietal lining. They are primarily used to treat heartburn, Gastroesophageal Reflux Disease (GERD), peptic ulcers, and indigestion.

Parietal Cell Mechanism (Why H 2 blockers work so well)

  • ACh & Gastrin → bind to receptors → increase Intracellular Calcium (Ca 2+)
  • Histamine → binds H 2 Receptor → increases cAMP (via ATP)
  • Convergence: Both of these pathways ultimately converge to turn ON the Gastric K+/H+ Ion Pump (the Proton Pump), actively dumping severe acid (H+) into the stomach.
  • By taking an H 2 blocker, you sever the cAMP pathway, heavily crippling the parietal cell's ability to produce acid, allowing the ulcer to heal.

The "Tidine" Family (Table 62-1 Comparison)

You must know the relative potencies and dosing strategies of these drugs:

DrugRelative PotencyTypical Acute Ulcer DoseGERD Dose
Cimetidine1 (Least Potent)800 mg HS (at bedtime) or 400 mg bid (twice daily)800 mg bid
Ranitidine4 - 10x stronger300 mg HS or 150 mg bid150 mg bid
Nizatidine4 - 10x stronger300 mg HS or 150 mg bid150 mg bid
Famotidine20 - 50x stronger (Most Potent)40 mg HS or 20 mg bid20 mg bid
Exam Pearl

Cimetidine Side Effects

Although it is the historical prototype H 2 blocker, Cimetidine is famous on pharmacology exams primarily for its negative side effects.

  • It heavily inhibits Cytochrome P450 enzymes in the liver, causing massive drug interactions by preventing the breakdown of other drugs (like Warfarin or Diazepam), leading to toxicity.
  • It has strong anti-androgenic effects (it blocks testosterone receptors). In men, chronic use can cause gynecomastia (breast tissue growth), decreased libido, and impotence.

Because of these issues, Ranitidine or Famotidine are usually preferred clinically, as they lack these severe side effects while being much more potent.

Advertisements

Quick Quiz

Medicine Day 8 Quiz

Medical Nursing

Privacy: Your details are used only for quiz tracking and certificates.

Advertisements

Histamine Pharmacology Read More »

Autacoids, Neuropeptides & Ergot Alkaloids

Autacoids, Neuropeptides & Ergot Alkaloids

Autocoids Neuropeptides & Ergot Alkaloids

Autacoids:


1. Introduction to Autacoids

The word "Autacoid" comes from the Greek words Auto (meaning "self") and Coids (meaning "healing/remedy"). They are frequently referred to as Local Hormones.

Conceptual Check

Autacoids vs. Classic Hormones

Unlike classical hormones (like insulin or thyroid hormone) which are produced by a specific gland, secreted into the blood, and travel long distances to reach a target, Autacoids are produced locally by many different tissues, act locally near their site of synthesis, and have a very brief lifespan.

Analogy: Think of them as the body's "neighborhood watch" system. If a house is broken into (tissue trauma), you don't wait for the national army (classical hormones) to arrive; the local neighborhood watch (autacoids) acts immediately at the exact site of injury to raise the alarm (inflammation/pain) and start repairs.

Why are Autacoids Important? (Functions)

  • Physiological: Regulate normal baseline organ functions (e.g., gastric acid secretion, local blood flow).
  • Pathophysiological (Reaction to Injuries): They are the primary drivers of inflammation, pain, allergy, and the body's response to tissue trauma.
  • Transmission and Modulation: They act as mediators that fine-tune pain signals and nerve responses.
Everyday Clinical Example: When you take an NSAID like Ibuprofen for a sprained ankle, you are specifically blocking the production of a lipid autacoid called a Prostaglandin. By shutting down this local autacoid, you stop the localized pain and swelling!

Classification of Autacoids

Autacoids are categorized by their chemical structure:

Chemical ClassExamples & Origin
A. Amine Derivatives
  • Histamine (derived from the amino acid Histidine)
  • Serotonin (derived from the amino acid Tryptophan)
B. Lipid Derivatives
  • Eicosanoids: Prostaglandins, Thromboxane, Leukotrienes.
  • Others: Interleukins, Platelet Activating Factor (PAF).
C. Peptide Derivatives
  • Kinins: Bradykinin.
  • Renin-Angiotensin system.
  • Neuropeptides.

2. Neuropeptides

Neuropeptides are small, protein-like molecules (short chains of amino acids) used by neurons to communicate with each other. They act in an autocrine (acting on the cell that released it) or paracrine (acting on immediate neighboring cells) manner.

Exam Trap: Neuropeptides vs. Classical Neurotransmitters

Classical neurotransmitters (like dopamine, serotonin, glutamate) are fired into the synapse and then quickly sucked back up by reuptake pumps to be recycled and used again.

NEUROPEPTIDES ARE NOT RECYCLED. Once they are secreted, they are broken down by specific enzymes (peptidases) and destroyed. The neuron must synthesize entirely new ones from the cell body (which takes time) and transport them down the axon. Do not forget this distinction!

General Functions of Neuropeptides

They are heavily responsible for higher-order brain functions and systemic regulation, including:

  • Analgesia (pain regulation)
  • Food intake (appetite stimulation/suppression)
  • Learning & Memory
  • Metabolism & Reproduction
  • Social Behaviors

Key Examples include: Neuropeptide Y (NPY), Cholecystokinin (CCK), Tachykinins (Substance P, Neurokinin), Arginine Vasopressin (AVP), and Corticotropin-Releasing Factor (CRF).

Neuropeptide Y (NPY)

NPY is a 36-amino acid peptide that acts as a potent neurotransmitter in both the Brain and the Autonomic Nervous System (ANS).

LocationSourcePhysiological Actions
Brain (Central NPY)Produced mainly by the Hypothalamus.
  • ↑ Food intake (Potent appetizer/orexigenic)
  • ↑ Storage of energy as fat
  • ↓ Anxiety and stress
  • ↓ Voluntary alcohol intake
  • ↓ Blood pressure and pain perception
  • Regulates circadian rhythm and controls epileptic seizures.
ANS (Peripheral NPY)Produced mainly by sympathetic neurons.
  • Strong Vasoconstrictor
  • Promotes the growth of fat tissue.

NPY Receptors & Mechanisms

NPY acts on G-Protein Coupled Receptors (GPCRs). Mammals have 5 types (Y1-Y5), but humans only express 4 functional types.

  • Y1 (NPY1R) & Y5 (NPY5R): These are the Feeding Stimulators (Appetizers). Activation leads to massive hunger.
  • Y2 (NPY2R) & Y4 (NPY4R): These act as Appetite Inhibitors (Anorectic).
  • Mechanism of Action: NPY receptors are Gi-coupled (Inhibitory G-protein). When NPY binds, the Gi subunit is released, which inhibits the enzyme adenylate cyclase. This stops the conversion of ATP into the 2nd messenger cAMP.
Clinical Scenario

Anti-Obesity Drugs and NPY

Because Y1 and Y5 receptors powerfully drive hunger and fat storage, pharmaceutical companies are actively researching Y1/Y5 Antagonists as therapeutic targets for obesity. Blocking these receptors could shut off the brain's unnatural drive to overeat. Conversely, chronic stress increases NPY release in the periphery, which promotes the growth of visceral fat (explaining why chronic stress often leads to weight gain!).


3. Tachykinins (TAC) & Substance P

Tachykinins form the largest family of neuropeptides. They get their name because they induce a rapid ("tachy") contraction of gut tissues.

  • Chemical Characteristic: All tachykinins share a common "C-terminal" sequence: "Phe-X-Gly-Leu-Met-NH2" (Where 'X' is either an aromatic or aliphatic amino acid, and COOH-terminus is the end of the protein chain).
  • Synthesis Pathway: Preprotachykinin → Protachykinin → Tachykinin.

Tachykinin Genes and Products

  • TAC-1 Gene produces: Neurokinin A, Neurokinin K, Neuropeptide γ, and Substance P (SP).
  • TAC-3 Gene produces: Neurokinin B.

Tachykinin Receptors (GPCRs)

Tachykinin receptors are Gq-coupled. Activation leads to the activation of Phospholipase C (PLC), which chops PIP2 into IP3 and DAG. This ultimately causes a massive release of intracellular Calcium. There are three main receptors, each with a preferred agonist:

  • NK1R: Prefers Substance P.
  • NK2R: Prefers Neurokinin A.
  • NK3R: Prefers Neurokinin B.

Substance P (SP)

Substance P is an Undecapeptide (a chain of 11 amino acids). It is a highly potent mediator of pain signaling and inflammation.

  • Receptor: Primarily binds to NK1R. The binding occurs via specific amino acid residues on the extracellular loops and transmembrane regions of the NK1 receptor.
  • Physiological Roles:
    • Promotes wound healing in humans (especially non-healing ulcers).
    • Acts as a potent vasodilator. This vasodilation is entirely dependent on the release of Nitric Oxide (NO) from the endothelium.
    • Transmits intense, burning pain signals to the brain (Neurogenic Inflammation).
Clinical Application

Substance P Antagonists (SPA)

By blocking or depleting Substance P, we can block pain and severe nausea.

  • Capsaicin: The active ingredient in chili peppers! Clinically used as a topical analgesic cream for arthritis and diabetic neuropathy.
    Mechanism: It initially causes a burning sensation (triggering SP release), but it eventually forces the nerve to release ALL of its Substance P. Because neuropeptides take a long time to synthesize (they aren't recycled), the nerve is left empty of Substance P, rendering it completely unable to transmit pain signals for weeks!
Oncology Magic

The "-pitant" Drugs

  • Aprepitant: Used heavily in oncology as an antiemetic drug to treat severe, delayed nausea and vomiting caused by cancer chemotherapy.
  • Fosaprepitant: An IV prodrug form of Aprepitant used for adult chemo patients.
  • Casopitant: Has dual antidepressant and antiemetic activities.
  • Vestipitant: Under trial for treating tinnitus (ringing in ears) and insomnia.
  • Maropitant: FDA-approved veterinary antiemetic for dog/cat motion sickness.

Exam Hint: If a drug ends in "-pitant", it is an NK1 Receptor Antagonist used to stop Puking (Emesis)!

Neurokinin A (Substance K)

Binds primarily to NK2R (Gq coupled → Inositol phosphate + Calcium 2nd messengers).

  • Oncology Role: High circulating levels of Neurokinin A serve as an independent indicator of poor prognosis in certain cancers, specifically carcinoid tumors.
  • Asthma Role: Neurokinin A is a powerful bronchoconstrictor. Therefore, selective NK2 receptor antagonists (like MEN 11420) are being studied to suppress bronchial constriction in asthmatics. They may also possess anti-inflammatory effects.

Note: Standard asthma drugs like fluticasone (corticosteroid) and montelukast (leukotriene antagonist) also happen to indirectly reduce NKA-induced bronchoconstriction.


4. Kinins & Bradykinin

Kinins are potent peptide autacoids involved in the inflammatory response. The most famous and clinically relevant is Bradykinin.

Synthesis and Metabolism

  • Synthesis: Bradykinin is not stored; it is created on-demand. An enzyme called Kallikrein acts as molecular scissors, cutting (proteolytic cleavage) a circulating protein called Kininogen to form active Bradykinin.
  • Metabolism (Breakdown): Because it is so potent, Bradykinin must be destroyed quickly. It is broken down by three "kininase" enzymes:
    1. Angiotensin-Converting Enzyme (ACE) - This is the most clinically important one!
    2. Aminopeptidase P (APP)
    3. Carboxypeptidase N (CPN)

Receptors and Actions

Kinins activate B1, B2, and B3 receptors, which are linked to Phospholipase C / A2 (PLC/A2). The B2 receptor mediates the majority of Bradykinin's classic effects:

  • Cardiovascular:
    • Potent Vasodilation: It forces the endothelium to release Prostacyclin (PGI2), Nitric Oxide (NO), and Endothelium-Derived Hyperpolarizing Factor (EDHF). This leads to a massive drop in blood pressure.
    • Cardiac Stimulation: The sudden drop in BP triggers a compensatory reflex tachycardia (fast heart rate) and increased cardiac output.
    • Coronary Vasodilation: Acts as a cardiac anti-ischemic agent (protects the heart from lack of oxygen).
  • Smooth Muscle: Causes contraction of NON-vascular smooth muscle, leading to bronchoconstriction (lungs) and gut cramps.
  • Inflammation & Pain: Radically increases vascular permeability (causing fluids to leak out into tissues = edema/swelling) and directly stimulates and sensitizes pain nerve endings (nociceptors).
  • Kidneys: Causes natriuresis (excretion of sodium in urine), further dropping BP.

Crucial Board Exam Concept: ACE Inhibitors and Bradykinin

Scenario: A 55-year-old patient with hypertension is prescribed Lisinopril (an ACE Inhibitor). Weeks later, they return complaining of a relentless, dry, hacking cough. In a worst-case scenario, they return with massive, life-threatening swelling of their lips, tongue, and throat. What happened?

The Science: The enzyme ACE has two jobs in the body. Job 1 is to create Angiotensin II (which raises BP). Job 2 is to destroy Bradykinin.

When you give a patient an ACE Inhibitor, you block the destruction of Bradykinin. Bradykinin levels skyrocket. This is actually good for blood pressure (because Bradykinin is a vasodilator), but it also causes fluid leakage and bronchoconstriction in the lungs, triggering a dry cough (affecting up to 20% of patients). In severe, rare cases, this excessive Bradykinin causes massive facial and airway swelling known as Angioedema, which is a medical emergency requiring immediate airway management.

Pharmacological Manipulation of Kinins

We can manipulate this system by either stopping Bradykinin from being made, or blocking its receptors.

1. Kallikrein Inhibitors (Stop the synthesis of Bradykinin)

  • Aprotinin: Used to treat acute pancreatitis, carcinoid syndrome (which dumps excessive peptides), and hyperfibrinolysis.
  • Ecallantide: A human plasma kallikrein inhibitor given via subcutaneous injection to treat severe inflammation (like hereditary angioedema).

2. Bradykinin Antagonists (Block the B2 Receptor)

  • Deltibant: A novel antagonist used for Severe Systemic Inflammatory Response Syndrome (SIRS) and Sepsis.
  • Icatibant: A synthetic decapeptide that acts as a potent, competitive antagonist of the B2 receptor. Used primarily for Hereditary Angioedema (a genetic condition causing severe, unprovoked swelling underneath the skin because the body overproduces bradykinin).
  • Pharmacokinetics of Antagonists: Usually given SubQ (30mg). Half-life is 1-2 hours. Rapid onset within an hour. Local injection site reactions are common but transient. Drug Interaction: ACE inhibitors block B2 receptor desensitization, potentiating bradykinin effects far beyond just blocking its hydrolysis!
Natural Note: Bromelain, an extract from pineapple stems/leaves, suppresses trauma-induced swelling by preventing the release of bradykinin into the bloodstream.

5. Ergot Alkaloids

Ergot alkaloids are a fascinating and dangerous class of compounds produced by Claviceps purpurea, a fungus that infects grains, particularly rye.

Historical & Toxicological Context

St. Anthony's Fire (Ergotism)

Accidental ingestion of grain contaminated with this fungus leads to a horrific disease known as Ergotism. In the Middle Ages, this was called "St. Anthony's Fire" because victims felt a burning pain in their limbs and sought help from St. Anthony's monks. Symptoms include:

  • Dementia and florid hallucinations (Ergot compounds mimic serotonin/LSD).
  • Prolonged, severe vasospasm which completely cuts off blood supply to the limbs, eventually resulting in dry gangrene and requiring amputation.
  • Uterine smooth muscle stimulation resulting in violent cramps and spontaneous abortion.

Epidemiology: Epidemics mandate continuous grain surveillance (e.g., the Karamoja incidence in Uganda). Poisoning of grazing animals is also common.

Chemistry and Major Families

All ergot alkaloids share a tetracyclic ergoline nucleus. The fungus naturally synthesizes acetylcholine, histamine, and tyramine alongside the unique alkaloids. There are two major families:

  • Amine Alkaloids: Lysergic acid diethylamide (LSD), Ergonovine, Methysergide, 6-methylergoline, Lysergic acid.
  • Peptide Alkaloids: Ergotamine, α-ergocryptine, Bromocriptine.

Pharmacokinetics: They are variably absorbed from the GI tract. Oral absorption of ergotamine is significantly improved by co-administering Caffeine (caffeine also acts as a cranial vasoconstrictor, helping with migraines). They are extensively metabolized in the liver.

Pharmacodynamics & Receptor Action

Ergots are considered "dirty drugs" because they lack specificity. They act as agonists, partial agonists, and antagonists across three major receptor families:

  1. Alpha-adrenoceptors: Causes massive vasoconstriction.
  2. Serotonin (5-HT) Receptors: Especially 5-HT1A, 5-HT1D, and 5-HT2.
  3. Dopamine (D2) Receptors: In the CNS, primarily acting as agonists.
Ergot Alkaloidα-AdrenoceptorDopamine ReceptorSerotonin (5-HT2)Uterine Stimulation
Bromocriptine-+++ (Strong Agonist)-0
Ergonovine++- (Partial Agonist)+++ (Very Strong)
Ergotamine-- (Partial Agonist)0+ (Partial Agonist)+++
LSD0+++-- (Peripheral Antagonist)
++ (CNS Agonist)
+

6. Clinical Uses of Ergot Alkaloids

1. Central Nervous System & Hyperprolactinemia

  • LSD: A powerful hallucinogen. Acts as a potent peripheral 5-HT2 antagonist, but behavioral effects are mediated by agonist effects at pre/postjunctional 5-HT2 receptors in the CNS.
  • Bromocriptine & Cabergoline: These are highly selective Dopamine (D2) Agonists. Dopamine naturally suppresses the pituitary gland from releasing Prolactin. Therefore, these drugs are given to treat Hyperprolactinemia (excess prolactin usually caused by pituitary secreting tumors or antipsychotic drugs).
    Clinical note: High prolactin causes amenorrhea (loss of periods) and infertility in women, and galactorrhea (milky discharge) in both sexes. Bromocriptine (2.5mg 2-3x daily) suppresses the secretion and can even shrink pituitary tumors.
Neurology

2. Migraine Treatment

Migraines involve massive, painful vasodilation of cranial blood vessels. Ergotamine potently constricts human blood vessels (partial agonist at alpha-receptors and 5-HT2 receptors). Its antimigraine action is also linked to action on prejunctional neuronal 5-HT receptors.

  • Ergotamine: Highly specific for migraine pain, but only effective if given early in the attack. It becomes progressively less effective if delayed. Often combined with caffeine to enhance GI absorption.
  • The Danger: Because ergotamine dissociates very slowly from the alpha-receptor, the vasoconstriction is long-lasting and cumulative. Max dose limits: No more than 6mg per attack, and NO MORE than 10mg per week, or the patient risks gangrene.
  • Dihydroergotamine: Given IV (0.5-1mg) or intranasally for intractable, severe migraines lasting >72 hours.
Obstetrics

3. Postpartum Hemorrhage

The uterus possesses alpha-1 and serotonin receptors. During pregnancy, the dominance of alpha-1 receptors increases dramatically, making the uterus at term extremely sensitive to ergot alkaloids.

  • Ergot derivatives induce a powerful, prolonged spasm of the uterine muscle (unlike natural, rhythmic labor contractions).
  • ABSOLUTE CONTRAINDICATION: Never give ergots before delivery, as the prolonged tetanic contraction will suffocate the fetus or rupture the uterus.
  • Use: Used strictly for the control of late uterine bleeding (Postpartum hemorrhage) after the placenta has been delivered. Note: Oxytocin is the 1st line drug, but if it fails, Ergonovine maleate (0.2 mg IM) is the Drug of Choice among ergots because it works within 1-5 minutes and is less toxic than ergotamine.

Toxicity & Contraindications of Ergots

  • GI Disturbances: Diarrhea, nausea, vomiting (due to activation of medullary vomiting center and GI serotonin receptors).
  • Prolonged Vasospasm: Overdose of ergotamine leads to ischemia, bowel infarction (requires surgical resection), and gangrene (requires amputation). Treatment: Reversible with massive peripheral vasodilators like Nitroprusside or Nitroglycerin.
  • Contraindications: Pregnant patients (causes abortion/fetal distress). Patients with obstructive vascular disease (Peripheral Artery Disease, Coronary Artery Disease) and collagen diseases. Crucial Note: Never combine Ergotamine with Triptans (modern migraine drugs) within 24 hours, as both cause massive vasoconstriction and will trigger a heart attack or stroke!

7. Bonus Section: Self-Study Autacoids Guide

Your lecture noted to read up on these. Here is a simplified summary to ensure your knowledge is 100% complete for the exam, complete with clinical context:

Renin-Angiotensin System

Renin (from kidney) converts Angiotensinogen (from liver) to Angiotensin I. ACE (from lungs) converts AT-I to Angiotensin II (AT-II). AT-II is a massive vasoconstrictor and triggers Aldosterone release (retains sodium/water), sharply raising Blood Pressure.

Clinical Context: We block this system with ACE Inhibitors (Lisinopril) or ARBs (Losartan) to treat hypertension and heart failure.

Nitric Oxide (NO)

A gas that acts as a localized autacoid. Synthesized by eNOS in blood vessels. It diffuses into smooth muscle, increases cGMP, and causes profound vasodilation.

Clinical Context: Sildenafil (Viagra) works by preventing the breakdown of cGMP, vastly prolonging the vasodilatory effects of Nitric Oxide to maintain an erection.

Oxytocin & Vasopressin

Peptides from the posterior pituitary. Oxytocin causes rhythmic uterine contractions and milk let-down. Vasopressin (ADH) retains water in the kidney and constricts blood vessels at high doses.

Clinical Context: Synthetic Oxytocin (Pitocin) is used to safely induce labor. Vasopressin is given during cardiac arrest to clamp blood vessels and force blood to the brain.

Endothelins

The exact opposite of NO. They are the most potent naturally occurring vasoconstrictors in the human body.

Clinical Context: Endothelin receptor antagonists (like Bosentan) are used specifically to treat Pulmonary Arterial Hypertension by stopping this massive vessel clamping in the lungs.

Cholecystokinin (CCK)

Found in the gut and brain. In the gut, it stimulates gallbladder contraction and pancreatic secretion (digestion). In the brain, it acts as a satiety signal (tells you to stop eating) and is heavily implicated in anxiety, panic disorders, and social behavior modulation.

Advertisements

Quick Quiz

Gynaecology Day 7 Quiz

Gynaecology

Privacy: Your details are used only for quiz tracking and certificates.

Advertisements

Autacoids, Neuropeptides & Ergot Alkaloids Read More »

Eicosanoids Pharmacology

Autocoids — Eicosanoids

Autocoids — Eicosanoids

Eicosanoids Pharmacology


1. Introduction to Eicosanoids

Definition: Eicosanoids are biological signaling molecules (local hormones/autacoids) that are products of polyunsaturated long-chain fatty acids. The prefix "Eicosa-" means 20 in Greek, because these molecules are almost entirely derived from 20-carbon essential fatty acids, most commonly Arachidonic Acid.

Hormones vs. Eicosanoids (The "Global Email" vs. "Sticky Note" Analogy)

Unlike regular hormones (like insulin) which are stored in glands and travel globally through the blood, eicosanoids are not stored. They are highly unstable and have a half-life of seconds to minutes. Therefore, they are synthesized on demand from cell membrane lipids and act locally right where they are made (paracrine action on neighbors, or autocrine action on themselves).

Major Classifications

Eicosanoids are divided into families based on the specific enzyme that creates them from the raw material:

  • a) Cyclooxygenase (COX) derivatives: These include the Prostaglandins (PGs) and Thromboxane (TXA 2).
  • b) Lipoxygenase (LOX) products: These include the Leukotrienes (LTs) and Lipoxins.
  • c) Cytochrome P450 (CYP) Epoxyoxygenase pathway: Produces EETs (Epoxyeicosatrienoic acids).

2. The Synthesis Cascade (The Arachidonic Acid Pathway)

To understand the drugs, you MUST understand how eicosanoids are made. Picture a cell membrane. The lipids in that membrane hold the raw material (Arachidonic Acid) locked away safely.

STEP 1: THE RELEASE

Cell Membrane Phospholipids (Diacylglycerol or Phospholipid)
↓ Enzyme: Phospholipase A 2 (PLA 2) (or Phospholipase C)
Arachidonic Acid (Free and active)

Exam Gold: The Corticosteroid Blockade

Exam Note: Corticosteroids (like Prednisone or Dexamethasone) stimulate the production of a protein called Annexin A1 (also known as Lipocortin-1), which completely blocks Phospholipase A 2. This shuts down the ENTIRE cascade right at the top. No Arachidonic Acid means no prostaglandins and no leukotrienes. This is exactly why steroids are such incredibly powerful, broad-spectrum anti-inflammatories compared to NSAIDs!

Once Arachidonic Acid is free, it acts as a crossroads and can go down one of three enzymatic paths:

Path A: The COX Pathway

Arachidonic Acid + COX-1 or COX-2 (PGH 2 Synthase / Peroxidase) → PGG 2 → Prostaglandin H 2 (PGH 2).

PGH 2 is the unstable "parent" molecule. Depending on the specific tissue enzymes present, PGH 2 becomes:

  • Prostaglandins: PGE 2, PGF 2α, PGD 2.
  • Prostacyclin (PGI 2): Synthesized via Prostacyclin synthase (primarily in vascular endothelium).
  • Thromboxane (TXA 2): Synthesized via Thromboxane synthase (primarily in platelets).
Path B: The LOX Pathway

Arachidonic Acid + 5-LOX (Lipooxygenase + FLAP protein) → 5-HPETE.

5-HPETE becomes:

  • Leukotrienes: LTA 4 → LTB 4, LTC 4, LTD 4, LTE 4.
  • HETEs: (e.g., 8-HETE, 12-HETE, 15-HETE) - play crucial roles in inflammation and immune cell recruitment.
Path C: Cytochrome P450 Pathway

Arachidonic Acid + CYP Epoxygenases → EETs.

These play a role in maintaining vascular tone (vasodilation), renal function, and overall cardiovascular protection.


3. Mechanism of Action and Receptors

Eicosanoids do not enter cells. They bind to cell surface receptors that are all coupled to G-proteins (GPCRs).

Crucial Second Messenger Mechanisms

You must know whether they cause relaxation or contraction at the cellular level (tying back to your signaling lectures!):

  • Relaxers (PGI 2 and PGE 2): Link to Gs proteins. Increase Adenylyl Cyclase → Increases cAMP → Decreases intracellular Calcium (Ca++). Result: Smooth muscle relaxation and Vasodilation.
  • Contractors (TXA 2, PGF 2α): Link to Gq proteins. Activate Phospholipase C → Increases IP 3 → Increases intracellular Calcium (Ca++). Result: Smooth muscle contraction, Vasoconstriction, and Platelet Aggregation.

4. Physiological & Pharmacologic Effects by System

This is where the exam will test your clinical application. Memorize these specific receptor actions:

A. The Vasculature (Blood Vessels)

  • PGEs (PGE 1, PGE 2): Potent vasodilators.
  • Prostacyclin (PGI 2): Potent vasodilator. Can produce profound hypotension (low blood pressure).
  • Thromboxane A 2 (TXA 2): Potent vasoconstrictor.
  • Leukotrienes (LTC 4, LTD 4): Cause massive capillary leakiness (vascular permeability), contributing heavily to the swelling (edema) seen in severe inflammation.
  • **Alprostadil (PGE 1): Specifically dilates the ductus arteriosus in neonates.

B. Platelets (The Blood Clotting Tug-of-War)

There is a constant balance (a "see-saw") in your blood between two eicosanoids to prevent you from bleeding out or forming fatal clots:

  • Prostacyclin (PGI 2): Produced by healthy blood vessel walls. It INHIBITS platelet aggregation. (Mnemonic: Prostacyclin keeps blood CYCLING smoothly).
  • Thromboxane A 2 (TXA 2): Produced by platelets. It is a massive platelet activator/aggregator. (Mnemonic: Thromboxane causes THROMBI / clots).

Inflammation (Leukocytes): LTB 4 is a powerful chemotactic agent (it acts as a chemical beacon, attracting eosinophils, monocytes, and neutrophils to the site of injury). Conversely, prostaglandins generally inhibit cellular and humoral immunity to keep the immune system from overreacting.

C. The Lungs (Bronchial Tone)

  • Prostaglandins: Have mixed effects on bronchial muscle (PGE 1/PGE 2 cause bronchodilation, PGD 2/PGF 2α cause constriction).
  • TXA 2: Causes bronchoconstriction. Inhibitors of thromboxane will therefore reduce the bronchoconstrictive response.
  • Leukotrienes (LTC 4, LTD 4): Extremely potent bronchoconstrictors. These are the main culprits in deadly asthma attacks!

D. The Uterus (Obstetrics)

  • PGE 2 and PGF 2α: Cause powerful uterine contractions, especially in a pregnant uterus.
  • Clinical Tie-In (Dysmenorrhea): Overproduction of PGE 2 and PGF 2α during menstruation causes severe uterine cramping (primary dysmenorrhea). This is why taking an NSAID (which blocks these prostaglandins) cures menstrual cramps!
  • Clinically, synthetic versions are used as abortifacients (to induce medical abortions) or to induce labor at term.

E. Gastrointestinal Tract (GIT)

  • PGEs and PGI 2: Inhibit gastric acid secretion (which is normally stimulated by feeding, histamine, or gastrin).
  • They act as a shield, promoting the maintenance of the gastric mucosa by stimulating heavy mucus and bicarbonate secretion.
  • Clinical Tie-In: This is exactly why taking NSAIDs (which block PGE production) causes stomach ulcers! You strip away the stomach's protective mucus shield.

F. The Kidneys

  • PGE 2 and PGI 2: Cause renal vasodilation (specifically of the afferent arteriole), increase Renal Blood Flow (RBF), increase GFR, and promote diuresis (water excretion). (If a patient takes too many NSAIDs, they lose this vasodilation, the kidney starves of blood, leading to Acute Kidney Injury).
  • TXA 2: Causes renal vasoconstriction and has an ADH-like action (retains water).

G. Central Nervous System (CNS) & Eye

  • CNS: PGE 2 is the primary mediator of Fever, Pain perception, and Sleep. When a virus attacks you, the brain generates PGE 2 to reset the hypothalamus thermostat, causing fever.
  • Eye: PGF 2α regulates the outflow of aqueous humor.

5. Clinical Pharmacology: Uses of Prostanoids and Analogues

In pharmacology, we create synthetic versions (analogs) of these molecules to treat diseases.
Mnemonic trick: If a drug name ends in "-prost" or has "prost" in the middle, it is a prostaglandin analog!

Group 1: Prostaglandin E 1 (PGE 1) Analogs

Drug NameClinical Application & Mechanism
Alprostadil
(IV infusion, IV inj, Intracavernosal)
1. Patency of Ductus Arteriosus: Given to neonates born with severe congenital heart disease (e.g., Transposition of the Great Arteries) to keep the ductus arteriosus open, allowing oxygenated blood to mix until surgery can be performed. Side effect: Long-term use leads to ductus fragility and rupture.

2. Male Impotence: Injected directly into the penis. Increases cAMP → decreases Ca++ → relaxes trabecular smooth muscle and dilates cavernosal arteries, enhancing penile erection.
Misoprostol
(Oral)
1. Peptic Ulcers: Binds to PG receptors on parietal cells → decreases cAMP → inhibits proton pump → decreases acid secretion. It also increases mucous/bicarbonate and mucosal blood flow. Used specifically for NSAID-induced ulcers. Dose: 200μg QD.

2. Obstetrics (1st Trimester Abortion): Given orally with Mifepristone or Methotrexate in the first few weeks to soften the cervix and cause uterine contractions, expelling contents.

*Side Effects: Severe GIT discomfort and diarrhea.
Lubiprostone
(Oral)
Chronic Constipation: Activates Type 2 Chloride (Cl-) channels in intestinal epithelial cells. Cl- is secreted into the gut, followed passively by Na+ and water. This increases stomach content liquidity and stimulates smooth muscle passage of stool.

*Note: Enoprostil is another PGE 1 analog used similarly to Misoprostol for NSAID ulcers/chronic smokers.

Group 2: Prostaglandin F 2α (PGF 2α) Analogs

Drug NameClinical Application & Mechanism
Latanoprost, Bimatoprost, Travoprost, Unoprostone
(Topical Eye Drops)
Treating Open-Angle Glaucoma: These agents increase the outflow of aqueous fluid via the uveoscleral pathway, drastically lowering intraocular pressure.

*Key Side Effect (Exam Gold): Bimatoprost causes dramatic elongation, thickening, and darkening of eyelashes (hypertrichosis). This "side effect" is now used commercially (as the drug Latisse) to treat eyelash thinning!
Carboprost
(IM, Intra-amniotic)
1. Post-partum Hemorrhage (PPH): Highly effective at violently contracting the uterus to clamp down on bleeding vessels after birth.

2. Mid-Trimester Abortion: Intra-amniotic injection. Least used for this now due to severe side effects.

*Key Side Effect: Can cause severe anaphylactic shock and CVS (cardiovascular) collapse.
Dinoprost
(Intra-amniotic inj)
Mid-trimester (2nd Trimester) Abortion.

Group 3: Prostaglandin E 2 (PGE 2) Analogs

Drug NameClinical Application & Mechanism
Dinoprostone
(Vaginal tab/gel/pessary)
Induction of Labour & Cervical Ripening: Used vaginally at full term to induce labor (improves the "Bishop score" by physically softening the cervix).
*Note: Oxytocin is usually the Drug of Choice (DOC) for labor induction. PGs are only used when Oxytocin is contraindicated (e.g., Renal failure, Pre-eclampsia, Eclampsia) because PGs do not cause Na+/water retention like oxytocin does.

Also used for Mid-Term Abortion.
*Side Effect: Prolonged bleeding.
Gemeprost / Demeprost / Denoproste
(Vaginal pessary)
Used vaginally for cervical priming in early pregnancy.

Group 4: Prostacyclin (PGI 2) Analogs

Drug NameClinical Application & Mechanism
Epoprostenol & Treprostinil
(IV Infusion)
1. Pulmonary Arterial Hypertension: Lowers peripheral pulmonary and coronary resistance. They increase cAMP → decrease Ca++ → cause profound pulmonary vessel dilation, taking the strain off the right side of the heart.

2. Renal Dialysis: Used to inhibit platelet aggregation so blood doesn't clot in the dialysis machine.
Beraprost
(Oral)
Used for Peripheral Vascular Disease (given orally, thrice a day) to dilate vessels in the legs.
Iloprost
(IM)
Decreases infarct size when given IM after a Myocardial Infarction (MI).

6. Clinical Uses of Eicosanoid Blockers

By blocking the synthesis pathways, we can treat various inflammatory and allergic conditions.

A. Asthma Management
  • Leukotriene Receptor Antagonists: Zafirlukast, Montelukast. They block the LTD 4 receptors in the lungs, preventing bronchoconstriction.
  • Lipoxygenase (LOX) Inhibitors: Zileuton. Stops the synthesis of leukotrienes entirely.

Clinical Scenario: If you give an asthmatic patient Aspirin, it blocks the COX pathway. The built-up Arachidonic acid has nowhere to go, so it is all "shunted" down the LOX pathway, creating massive amounts of Leukotrienes. This triggers a deadly asthma attack known as Aspirin-Exacerbated Respiratory Disease (AERD).

B. Anti-inflammatory & Analgesia
  • NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Block Cyclooxygenase (COX-1 and COX-2), preventing the creation of pain/fever-inducing prostaglandins. Used for Rheumatoid arthritis and Dysmenorrhea (menstrual cramps).
C. Antiplatelet Action
  • Aspirin (Low Dose): Aspirin irreversibly inhibits COX. At low doses (e.g., 81mg), it is highly selective for blocking TXA 2 in platelets (stopping clots) without totally destroying the protective PGI 2 in blood vessels. Because platelets do not have a nucleus, they cannot make new COX enzymes. The anti-clotting effect lasts for the entire lifespan of the platelet (7-10 days)!

7. Selective COX-2 Inhibitors (The "Coxibs")

Traditional NSAIDs (like Ibuprofen) block both COX-1 (which makes stomach-protecting mucus) and COX-2 (which makes inflammatory pain molecules). This causes stomach ulcers. Selective COX-2 Inhibitors were developed to be 10-20 times more selective for COX-2, aiming to stop pain without hurting the stomach. They are reversible inhibitors.

  • Celecoxib: Chemically a sulfonamide. Half-life of 11 hours.
  • Meloxicam: Related to Piroxicam. Preferentially selective COX-2 inhibitor.
  • Etoricoxib: Long half-life (22 hours). Requires strict monitoring of hepatic (liver) functions.
  • Nimesulide: A newer compound causing less gastric irritation.

Advantages of COX-2 Inhibitors:

  • Excellent Analgesic, Antipyretic (reduces fever), and Anti-inflammatory effects.
  • NO inhibition of protective gastric PGs = No gastric irritation/ulcers!
  • NO inhibition of platelet aggregation = Does NOT prolong bleeding time (making them safer before surgeries).

The Massive Disadvantage / Adverse Effects (The Vioxx Disaster)

Drugs like Valdecoxib and Rofecoxib (Vioxx) were completely WITHDRAWN from the market. Why?

Because COX-2 usually makes Prostacyclin (PGI 2) which stops clots, while COX-1 makes Thromboxane (TXA 2) which causes clots. If you selectively block ONLY COX-2, you eliminate the anti-clotting mechanism, leaving TXA 2 completely unopposed. This led to a massively higher risk of Cardiovascular thrombotic events (Myocardial Infarction / Heart Attacks and Strokes) in patients taking these drugs.


Other Side Effects: Renal toxicities (kidney damage) are exactly similar to non-selective NSAIDs. Celecoxib specifically can cause Skin Rashes (because it contains a sulfa group, triggering sulfa allergies).


8. Summary: Side Effects of Prostanoids

When giving synthetic prostanoids to a patient, you are basically causing a systemic inflammatory response. Effects are highly dose-related:

  • Systemic: Hypotension, fever, dizziness, flushing.
  • Respiratory: Bronchoconstriction (Cough is a notable side effect when using bronchodilators for asthma).
  • GI tract: Vomiting, severe diarrhea (especially Misoprostol and Enoprostil).
  • Severe reactions: Carboprost (anaphylactic shock, CVS collapse).
  • Neonatal: Alprostadil over-usage causes ductus fragility and rupture.
  • Bone/Kidney: PGE acting on EP4 receptors can increase osteoclast/osteoblast activity, inducing hypercalciuria (excess calcium in urine).

Advertisements

Quick Quiz

Eicosanoids Quiz

Pharmacology

Privacy: Your details are used only for quiz tracking and certificates.

Autocoids — Eicosanoids Read More »

Serotonin

Autocoids — Serotonin

Autocoids — Serotonin

Serotonin & Migraine Pharmacology


1. Brief Recap: What are Autacoids?

Before diving into Serotonin, remember the baseline definition from the start of the lecture. Autacoids are the body's local communication network.

  • Definition: Endogenous substances (made in the body) that act as biological factors or "local hormones". (Greek: Autos = self, Akos = remedy).
  • Characteristics: Present in very small amounts, have distinct biological activity, are short-living with a short duration of action, and act at or very close to their site of release.
  • Systemic Effect: Although they are "local", if produced in massive amounts, they can enter the circulation and cause whole-body (systemic) effects.
  • Functions: They regulate physiological baselines, mediate pathophysiological reactions to injuries (like inflammation), and modulate nerve transmission.
Analogy

Endocrine Hormones vs. Autacoids

Think of standard Endocrine Hormones (like insulin or thyroid hormone) as a company-wide email broadcast. They travel through the main server (the bloodstream) to reach every department in the body. In contrast, Autacoids are like sticky notes left on a coworker's desk. They are meant only for the immediate neighbor (local action) and are thrown away quickly (short duration of action).

Chemical Classification of Autacoids

Autacoids are classified into four main families based on their chemical structure:

1. Amines

Histamine, Serotonin (5-HT).

2. Polypeptides

Kinins, Oxytocin, Angiotensin, Vasopressin, Endothelins.

3. Fatty Acids

Prostaglandins, Leukotrienes, Thromboxanes, PAF (Platelet Activating Factor).

4. Others

Nitric Oxide (NO), Cytokines.


2. Serotonin (5-HT): Synthesis and Metabolism

Serotonin, chemically known as 5-hydroxytryptamine (5-HT), is an indoleethylamine. It is widely distributed in nature—found in plants (like bananas and pineapples), animal tissues, venoms, and insect stings.

A. The Synthesis Pathway

Serotonin is built from the amino acid L-tryptophan. This is a critical two-step process:

  1. L-Tryptophan
    ↓ (Enzyme: Tryptophan Hydroxylase) — *Rate Limiting Step*
  2. 5-Hydroxytryptophan (5-HTP)
    ↓ (Enzyme: Decarboxylase)
  3. 5-Hydroxytryptamine (Serotonin / 5-HT)
  • The Rate-Limiting Step: Hydroxylation at the C5 position is the bottleneck of the whole process. The body can only make Serotonin as fast as Tryptophan Hydroxylase works.
  • Experimental Blockers: You can chemically block this rate-limiting step using drugs like p-chlorophenylalanine (PCPA / fenclonine) and p-chloroamphetamine. Experimentally, these were used to reduce serotonin in carcinoid syndrome, but they are too toxic for clinical human use.

B. Inactivation and Metabolism

Once Serotonin does its job, it must be rapidly inactivated so it doesn't continuously overstimulate the body. It is metabolized primarily by the enzyme Monoamine Oxidase (MAO).

  • Serotonin (5-HT)
    ↓ (Enzyme: MAO)
  • 5-hydroxyindoleacetaldehyde
    ↓ (Enzyme: Aldehyde Dehydrogenase)
  • 5-HIAA (5-hydroxyindoleacetic acid) — *The Principal Metabolite*
Exam Trap!

The Carcinoid Tumor Diagnostic Test

Clinical Scenario: A patient presents with severe flushing, severe diarrhea, and right-sided heart valve issues. You suspect a Carcinoid Tumor (a rare gut tumor that secretes massive amounts of serotonin).

The Test: You measure the 24-hour urinary excretion of 5-HIAA (the final breakdown product). High 5-HIAA confirms massive serotonin synthesis.

The Trap: Before the test, you MUST prohibit the patient from eating foods rich in serotonin or tryptophan (e.g., Bananas, Pineapples, Plums). If they eat a bunch of bananas before the test, their body will metabolize that dietary serotonin, their urine 5-HIAA will skyrocket, giving a false positive for a tumor!

Clinical Scenario: MAO Inhibitors & Serotonin Syndrome

If a patient is taking a drug that blocks Monoamine Oxidase (an MAOI antidepressant like Phenelzine), the serotonin cannot be broken down. If this patient then takes another drug that increases serotonin (like an SSRI or MDMA/Ecstasy), serotonin builds up to lethal levels. This causes Serotonin Syndrome: hyperthermia, muscle rigidity, tremors, and potentially death.


3. Storage, Release, and Locations of 5-HT

Where is Serotonin found in Mammals?

  • The Gut (90%): Over 90% of all serotonin in the human body is located in the enterochromaffin cells of the gastrointestinal tract. (Deep Explanation: This is why SSRI antidepressants, which increase active serotonin everywhere, almost always cause GI upset, nausea, and diarrhea in the first week of use! The gut has far more serotonin receptors than the brain).
  • The Blood (Platelets): Serotonin floats in the blood stored safely inside platelets. Platelets don't make serotonin; they suck it up from the plasma using an active Serotonin Transporter (SERT). (Why? When you get cut, platelets clump together and release serotonin to cause local vasoconstriction, stopping the bleeding!).
  • The Central Nervous System (Nerve Endings): Found heavily in the raphe nuclei of the brainstem. These neurons synthesize, store, and release 5-HT as a true neurotransmitter controlling mood and sleep.
  • The Pineal Gland: Here, serotonin serves as a precursor. An enzyme (Hydroxyindole-O-methyltransferase) converts serotonin into Melatonin, the hormone that induces sleep.

How is it Stored?

Whether in a nerve ending or a platelet, serotonin is pumped into protective storage vesicles by a pump called the Vesicle-Associated Transporter (VAT).

Pharmacological Blockade: The drug Reserpine completely blocks VAT. If serotonin cannot get into the protective vesicle, it is left out in the open and is destroyed by MAO in the cytoplasm. Therefore, Reserpine severely depletes stored serotonin (just like it depletes catecholamines), which historically caused severe, suicidal depression in patients taking it for high blood pressure.


4. Physiological Actions of Serotonin

SystemSpecific Actions of 5-HT
Central Nervous System (CNS)Affects mood, sleep, appetite, temperature regulation, pain perception, blood pressure, and vomiting.
Deficiency: Causes depression, anxiety, migraines.
Neuroendocrine: Controls hypothalamic cells releasing anterior pituitary hormones.
Gastrointestinal (GI)Causes intense rhythmic contractions of the small intestines (via 5-HT4). Stimulates vomiting via the 5-HT3 receptors on vagal nerves.
Cardiovascular SystemPotent contraction of smooth muscle (via 5-HT2), causing constriction of veins. Exception: It does not contract skeletal muscle or heart muscle. Triggers Platelet aggregation (clotting) via 5-HT2.
Respiratory SystemCauses mild stimulation in healthy lungs, but triggers severe bronchoconstriction in asthmatics (via 5-HT2 in smooth muscles). (Explanation: Asthmatic airways are hyper-reactive to autacoids. Even a tiny bit of serotonin can trigger an asthma attack).

5. Serotonin Receptors (The Pharmacology Targets)

There are at least 15 types and subtypes of serotonin receptors. You must memorize the mechanisms of the main ones:

Crucial Mechanism Trap

Receptors 1 through 6 are all G-protein coupled receptors (GPCRs).
Receptor 5-HT3 is the ONLY exception! It is a Ligand-gated Na+/K+ ion channel. If an exam asks which receptor acts the fastest or doesn't use second messengers, the answer is always 5-HT3.

  • 5-HT1 (A-H): Found in CNS (usually inhibitory) and smooth muscles.
    • 5-HT1A: Role in Anxiety/Depression.
    • 5-HT1D / 1B: Role in Migraine (causes vasoconstriction when activated).
  • 5-HT2 (A-C): Found in CNS (usually excitatory). In the periphery, activation leads to vasodilation, contraction of bronchioles, GIT, uterine smooth muscle, and platelet aggregation.
  • 5-HT3: Found in the Area Postrema (the vomit center in the brain) and peripheral sensory/enteric nerves. Primary role: Nausea and Vomiting (especially from chemotherapy).
  • 5-HT4: Role in the management of irritable bowel syndrome (IBS) and constipation (stimulates GI motility).
  • 5-HT5 to 5-HT7: Novel targets for antidepressants and antipsychotics.

6. Serotonin Agonists & Migraine Management

Migraines are characterized by a variable duration involving nausea, vomiting, visual disturbances (auras), speech abnormalities, followed by a severe, throbbing headache.

Pathophysiology of a Migraine

  1. Involves the trigeminal nerve distribution to intracranial arteries.
  2. These nerves inappropriately release peptide neurotransmitters—especially Calcitonin Gene-Related Peptide (CGRP), which is an extremely powerful vasodilator. (Substance P and Neurokinin A are also involved).
  3. This causes massive vasodilation. Plasma and proteins leak out of the vessels, causing perivascular edema.
  4. This sudden swelling/edema stretches and activates pain nerve endings in the dura mater, causing the severe headache. (Deep Explanation: The headache is "throbbing" because the hyper-dilated blood vessels are physically pulsing against the stretched, sensitive nerves with every single heartbeat).

A. Acute Migraine Therapy: The Triptans (5-HT1D/1B Agonists)

Mechanism of Action: They have two hypothetical mechanisms:

  1. They activate 5-HT1D/1B receptors on presynaptic trigeminal nerve endings, which inhibits the release of vasodilating peptides (like CGRP).
  2. They act as direct vasoconstrictors, preventing the vasodilation and stretching of pain endings. By shrinking the blood vessel back down, it stops throbbing against the nerve.

Triptan Contraindications & Side Effects

Use: Acute severe migraine attacks (First-line therapy is Sumatriptan).

Side Effects: Tingling, warmth, dizziness, muscle weakness, neck pain. They can cause chest or throat pressure due to bronchospasms.

ABSOLUTE CONTRAINDICATION: Because Triptans heavily constrict blood vessels, they are strictly contraindicated in patients with Coronary Artery Disease (Angina) or previous heart attacks. Giving a triptan to someone with bad, clogged heart arteries can trigger a fatal myocardial infarction (heart attack)!

Pharmacokinetics of Triptans (Table 16-5)

You must know the basic routes and half-lives:

DrugRoutesTime to Onset (h)Half-Life (h)
AlmotriptanOral2.63.3
EletriptanOral24
FrovatriptanOral327 (Longest half-life by far!)
NaratriptanOral25.5
RizatriptanOral1 - 2.52
SumatriptanOral, nasal, Subcutaneous1.5 (0.2 for SubQ)2
ZolmitriptanOral, nasal1.5 - 32.8

B. Other Acute Migraine Drugs

  • Anti-inflammatory analgesics: Aspirin and Ibuprofen are helpful in controlling mild/moderate pain.
  • Antiemetics: For severe nausea and vomiting accompanying the migraine, parenteral Metoclopramide is highly helpful.
  • Ergot Alkaloids: (e.g., Ergotamine, Ergonovine). Act as partial agonists at 5-HT2, alpha, and other receptors. Cause severe vasoconstriction. Historical & Clinical Note

    Side effects of Ergots: Abortions (never give to pregnant women, it violently contracts the uterus), severe ischemia, and gangrene from prolonged vasoconstriction, GI distress. (Historically, consuming moldy rye bread infected with the ergot fungus caused "St. Anthony's Fire" — mass epidemics of people losing limbs to gangrene and hallucinating. This is suspected to have played a role in the Salem Witch Trials!)

C. Migraine Prophylaxis (Prevention)

These drugs do NOT stop an acute attack; they are taken daily to prevent recurrences:

  • Propranolol: Beta-blocker.
  • Amitriptyline: A Tricyclic Antidepressant (TCA) that blocks the reuptake of serotonin, used for neuropathic pain.
  • Valproic Acid & Topiramate: Anticonvulsants with good prophylactic efficacy.
  • Calcium Channel Blockers: Flunarizine is highly effective in trials. Verapamil has modest efficacy.

D. Other Serotonin Agonists

  • Buspirone: A partial 5-HT1A agonist used to treat Anxiety.
  • Fluoxetine (SSRI): A Selective Serotonin Reuptake Inhibitor. Keeps 5-HT in the synapse longer. Used for Depression.
  • LSD (Lysergic Acid Diethylamide): A 5-HT1A agonist. Used as an illicit drug of abuse; acts as a powerful hallucinogen.

7. Serotonin Antagonists (Blockers)


1. Methysergide and Cyproheptadine

Mechanism: Both are 5-HT1 and 5-HT2 antagonists.

  • Cyproheptadine is unique. It structurally resembles phenothiazine antihistamines. Therefore, it is a potent H1-receptor blocker AND a 5-HT2 blocker.
  • Actions: Prevents smooth muscle effects of both histamine and 5-HT. Has significant antimuscarinic effects (causes dry mouth) and causes strong sedation.
  • Clinical Use: Carcinoid tumor syndrome, other GI tumors, and cold-induced urticaria (hives).
    (Clinical Scenario: If a patient presents with Serotonin Syndrome from an antidepressant overdose, Cyproheptadine is the literal antidote because it aggressively blocks the 5-HT2 receptors!)

2. Atypical Antipsychotics (Receptors are in the CNS)

  • Olanzapine: A 5-HT2A antagonist with presynaptic effects. Used to decrease symptoms of psychosis and schizophrenia.
  • Clozapine: A 5-HT2A / 2C antagonist. Used for severe schizophrenia and psychosis.

3. Cardiovascular & Antiemetic Antagonists

  • Ketanserin: A 5-HT2 AND Alpha-1 antagonist. The alpha-blocking effect makes it a potent antihypertensive and useful for treating vasospasms.
  • Ondansetron: A pure 5-HT3 antagonist.
    • Mechanism: Blocks the activation of the 5-HT3 ion channel in the Area Postrema (Chemoreceptor Trigger Zone).
    • Clinical Use: The absolute gold standard for treating nausea and vomiting induced by Chemotherapy and Radiation, as well as post-operative nausea. (Deep Explanation: Chemotherapy drugs often damage the gut lining, causing enterochromaffin cells to dump massive amounts of serotonin. This serotonin hits the 5-HT3 receptors on the vagus nerve, sending a "vomit" signal to the brain. Ondansetron blocks this signal, revolutionizing cancer care by allowing patients to tolerate chemo!).

Advertisements

Quick Quiz

Serotonin Quiz

Pharmacology

Privacy: Your details are used only for quiz tracking and certificates.

Autocoids — Serotonin Read More »

Want notes in PDF? Join our classes!!

Send us a message on WhatsApp
0726113908

Scroll to Top
Enable Notifications OK No thanks